Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1050.Time spend outdoors in summer,49384,0.0296391908246199,0.0396692795930411,-0.0481125971777406,0.10739097882698,0.454977332320937
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1060.Time spent outdoors in winter,47316,-0.0379930833003774,0.043972370451752,-0.124178929385811,0.0481927627850566,0.387587393467302
EPHA2,Ephrin type-A receptor 2,Physical activities,X1070.Time spent watching television (TV),50551,0.269910650390418,0.0410410116066814,0.189470267641322,0.350351033139513,4.92435922409929e-11
EPHA2,Ephrin type-A receptor 2,Physical activities,X1080.Time spent using computer,47403,-0.168660326198004,0.039047168775337,-0.245192776997665,-0.0921278753983435,1.57282299549454e-05
EPHA2,Ephrin type-A receptor 2,Physical activities,X1090.Time spent driving,43321,-0.101797621031584,0.0444716795836098,-0.188962113015459,-0.014633129047709,0.0220914964314909
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1160.Sleep duration,51307,0.113463136928573,0.0351960378852676,0.0444789026734487,0.182447371183698,0.00126708465777055
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35375,-0.00784734243906336,0.0134888684508045,-0.0342855246026403,0.0185908397245135,0.560746653556681
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35375,0.00653664664688981,0.0129148514520319,-0.0187764621990928,0.0318497554928724,0.612780568119228
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35375,0.0304082849013971,0.0141531411917884,0.00266812816549178,0.0581484416373024,0.03171132561984
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35375,0.0103820846025948,0.01413274183075,-0.0173180893856752,0.0380822585908648,0.462603572246583
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35375,0.0322210397820034,0.014137492786223,0.00451155392100627,0.0599305256430005,0.0226938864724713
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35375,0.0353501869924552,0.0357110114343612,-0.0346433954188928,0.105343769403803,0.322263708495252
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35375,0.0166594785622077,0.0368886247184932,-0.055642225886039,0.0889611830104543,0.651561771629419
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35375,0.0186139400660901,0.0241794732455346,-0.0287778274951577,0.0660057076273379,0.441433689163078
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35375,0.0390706650665962,0.0175430711381869,0.00468624563574992,0.0734550844974425,0.0259745979945563
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35375,0.00238495282422731,0.0115651161916916,-0.0202826749114882,0.0250525805599429,0.836626225006364
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35375,0.0014201044965824,0.0174459426708731,-0.0327739431383288,0.0356141521314937,0.935126267518925
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35375,0.0193694522070641,0.00937511866201924,0.000994219629506361,0.0377446847846218,0.038865447824883
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35375,0.00205121289624454,0.01225603435339,-0.0219706144363999,0.026073040228889,0.867089512071869
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35375,0.0127609730554947,0.0174114053211784,-0.0213653813740149,0.0468873274850043,0.463641817705151
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35375,0.0102025237929356,0.0164115715547286,-0.0219641564543325,0.0423692040402037,0.534184129621165
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35375,0.0500457454052069,0.0251823297492107,0.000688379096753851,0.0994031117136599,0.0469292588263124
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35375,0.0261870405441835,0.0243709965905349,-0.0215801127732648,0.0739541938616318,0.282633149589832
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35375,0.019452627044072,0.0126628600116842,-0.00536657857882907,0.0442718326669731,0.124541653075819
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35375,0.0230613269094128,0.0120512970609877,-0.000559215330123042,0.0466818691489486,0.0557177992262957
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35375,-0.000630081983358831,0.0152043623812756,-0.0304306322506591,0.0291704682839414,0.966945770831587
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120040.Fatigue severity over the past week,35378,0.265269794292883,0.0768822334800407,0.114580616672003,0.415958971913762,0.000563624890887671
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,35376,0.167199870100871,0.076694125361051,0.0168793843932113,0.317520355808531,0.0292886151874692
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,35378,0.0617913687481432,0.0810968248337817,-0.097158407926069,0.220741145422355,0.446121540803049
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120098.Mobility problems today,35382,0.431746888486354,0.0834337610179305,0.268216716891211,0.595277060081498,2.35438420243186e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120099.Self-care problems today,35382,0.244283087243607,0.125645023669186,-0.00198115914799749,0.490547333635212,0.0519127507879029
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120100.Problems doing usual activities,35382,0.282942440857888,0.0806727395613847,0.124823871317574,0.441061010398201,0.000455916232238593
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120101.Pain or discomfort today,35382,0.170946404126432,0.0770896149292101,0.0198507588651801,0.322042049387684,0.0266249908291842
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120102.Anxiety or depression today,35382,0.22386971852087,0.0957637706750515,0.0361727279977692,0.411566709043971,0.019433042846864
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120103.Scale to indicate how health is today,35361,-0.0150134534716893,0.00409114553294718,-0.0230320987162658,-0.00699480822711283,0.000244844048249781
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35357,0.272493865550953,0.0981375045261757,0.0801443566796487,0.464843374422257,0.00550875823490579
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35348,0.244449800326754,0.101708985811175,0.045100188136851,0.443799412516656,0.0162717601300471
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35364,0.0643464619672289,0.0777187193339402,-0.0879822279272938,0.216675151861752,0.407736327352405
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35362,0.243423742121433,0.0796310834196258,0.0873468186189665,0.399500665623899,0.00224601399829921
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35373,0.365989437356272,0.111117012266643,0.148200093313651,0.583778781398892,0.000994238740483075
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,35353,0.187558028646254,0.10950670496759,-0.027075113090222,0.402191170382729,0.0868081844848608
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,35366,0.172690761471326,0.108459643164712,-0.0398901391315096,0.385271662074162,0.111388270887804
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35366,0.136530609136875,0.148503706448844,-0.154536655502859,0.427597873776609,0.357935352011507
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35346,0.788985942456335,0.213712888345523,0.370108681299111,1.20786320361356,0.000224597779475632
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33309,0.372272595378777,0.104175716886285,0.168088190281658,0.576457000475896,0.000356272725552392
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49588,0.286279131666399,0.0801632102041075,0.129159239666348,0.443399023666449,0.000356162393476779
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47871,0.102677531941536,0.0519477254724537,0.000859990015526946,0.204495073867546,0.0481066510959869
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1289.Cooked vegetable intake,50879,-0.241412164305026,0.0368681866856741,-0.313673810208947,-0.169150518401104,5.96262714928706e-11
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50125,-0.199304958901317,0.0383734581987315,-0.274516936970831,-0.124092980831803,2.07947696700551e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1309.Fresh fruit intake,50796,-0.0911121499777279,0.0379960864928403,-0.165584479503695,-0.0166398204517609,0.0164962185077384
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1319.Dried fruit intake,49654,-0.112028684164498,0.0384212726436118,-0.187334378545977,-0.0367229897830187,0.00355164752057958
EPHA2,Ephrin type-A receptor 2,Health and medical history,X134.Number of self-reported cancers,51511,0.409783645985167,0.0558110507502957,0.300393986514587,0.519173305455746,2.17088335554348e-13
EPHA2,Ephrin type-A receptor 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,51512,0.427504646233144,0.0398118158038959,0.349473487257508,0.50553580520878,7.83766446028953e-27
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X136.Number of operations, self-reported",51512,0.23373000355033,0.0372324148505241,0.160754470443303,0.306705536657358,3.50183947587324e-10
EPHA2,Ephrin type-A receptor 2,Health and medical history,X137.Number of treatments or medications taken,51512,0.476537359845022,0.0382289996387892,0.401608520552995,0.551466199137049,1.51553465766232e-35
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1438.Bread intake,50918,0.0175911599266835,0.00258753620740758,0.0125195889601646,0.0226627308932023,1.08514965733081e-11
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1458.Cereal intake,50567,0.13030885119076,0.036413064749544,0.0589392442816541,0.201678458099866,0.000346165559577521
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1488.Tea intake,50845,0.00919174599301051,0.00250997016267869,0.00427220447416027,0.0141112875118607,0.000250757980931526
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1498.Coffee intake,49907,-0.216316271039563,0.036746740034525,-0.288339881507232,-0.144292660571894,4.00109197300011e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1528.Water intake,49707,-0.00280399858762045,0.0365177727130951,-0.0743788331052868,0.068770835930046,0.938795737641999
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1568.Average weekly red wine intake,44405,-0.483739179237969,0.0443480957477464,-0.570661446903551,-0.396816911572386,1.33888617922144e-27
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,44401,-0.242740579664683,0.0457220496412295,-0.332355796961493,-0.153125362367873,1.11748002358703e-07
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,44448,-0.051687219717253,0.0499333136006363,-0.1495565143745,0.0461820749399943,0.30062696343805
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1598.Average weekly spirits intake,44386,0.0259838005484607,0.0473936018125069,-0.0669076590040529,0.118875260100974,0.583524568118605
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1608.Average weekly fortified wine intake,44434,0.125600031054781,0.0712804372583157,-0.0141096259715173,0.26530968808108,0.0780800985433397
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1737.Childhood sunburn occasions,45433,-0.177483822715643,0.0446310663114527,-0.26496071268609,-0.0900069327451954,7.01846268635189e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1807.Father's age at death,49472,-0.00555936913663827,0.00243014862395704,-0.0103224604395941,-0.000796277833682467,0.0221672076930078
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1845.Mother's age,32468,-0.0168606533951668,0.0116412929308512,-0.0396775875396351,0.00595628074930144,0.147615265844228
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1873.Number of full brothers,51101,0.0247440870207341,0.0348854440400871,-0.0436313832978366,0.0931195573393047,0.478148695057131
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1883.Number of full sisters,51107,-0.013392860510005,0.0351639257113848,-0.0823141549043193,0.0555284338843093,0.703303910399235
EPHA2,Ephrin type-A receptor 2,Physical measures,X20015.Sitting height,51359,-0.00202236005607271,0.00325127377208894,-0.00839485664936702,0.00435013653722161,0.53393456007626
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20016.Fluid intelligence score,36480,-0.260291019570793,0.0575027827119851,-0.372996473686284,-0.147585565455302,6.08992529887735e-06
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20018.Prospective memory result,36829,0.274158474654964,0.0682143485051336,0.140458351584902,0.407858597725026,5.89891672262615e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36362,0.0137245852495733,0.00438756385106571,0.00512496010148452,0.0223242103976621,0.00176666426310913
EPHA2,Ephrin type-A receptor 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36348,0.00705490074838267,0.0044065384578975,-0.00158191462909643,0.0156917161258618,0.109419429920708
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20023.Mean time to correctly identify matches,51215,0.0182081814153904,0.00263380192778662,0.0130459296369286,0.0233704331938522,4.86556905245129e-12
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48201,-0.00617817856335872,0.00546799313330194,-0.0168954451046305,0.00453908797791307,0.258540859486653
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,47773,-0.00439448298444328,0.0115868444077065,-0.027104698023548,0.0183157320546614,0.704495521855713
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,47740,-0.0106862249629425,0.0154094905916544,-0.0408888265225852,0.0195163765967001,0.488014963911377
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,47746,0.0127559925795434,0.0149054695869315,-0.0164587278108424,0.0419707129699292,0.392123487137122
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,47769,-0.0100506493424083,0.0102851781774457,-0.0302095985702019,0.0101082998853852,0.328484162639007
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#2.Illnesses of father_Stroke,47942,0.00857944275505585,0.00685549953090451,-0.00485733632551699,0.0220162218356287,0.2107791586147
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,47884,0.0055801128051225,0.00838207490846183,-0.0108487540154627,0.0220089796257077,0.50559846352376
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,47787,-0.011472953016755,0.0109392672316185,-0.0329139167907272,0.00996801075721713,0.294290141281843
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,47935,0.0184226279763371,0.00741012608188092,0.0038987808558505,0.0329464750968237,0.012922274690684
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,47930,0.0015204387957801,0.00688202706835485,-0.0119683342581954,0.0150092118497556,0.825150187598737
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,47808,0.0118317515789442,0.00976915663854391,-0.00731579543260184,0.0309792985904903,0.225859670968895
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49257,0.00515337785148886,0.00596511897431071,-0.00653825533816012,0.0168450110411379,0.387642879368766
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49107,-0.0138561504767709,0.00774789977754275,-0.0290420340407547,0.00132973308721292,0.0737307201859856
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49015,0.00386677480345873,0.0173338945843418,-0.0301076585818513,0.0378412081887688,0.823478703501218
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49042,0.0113787155884181,0.0107900329880128,-0.00976974906808705,0.0325271802449233,0.291640358593176
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,49190,0.00686242626420279,0.00655663904025407,-0.00598858625469519,0.0197134387831008,0.295279312044196
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49061,0.0204886242338126,0.0124642042449857,-0.00394121608635937,0.0449184645539846,0.100233919794404
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49046,-0.00106052192328201,0.010566618854625,-0.0217710948783471,0.0196500510317831,0.920055326811293
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49048,-0.0156191573914859,0.00931919287727819,-0.0338847754309511,0.00264646064797935,0.0937499417191642
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49095,0.0173857738432693,0.0104429111180599,-0.00308233194812801,0.0378538796346666,0.0959604667948446
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49236,-0.00295357551362076,0.00580930387490472,-0.014339811108434,0.00843266008119249,0.61116331087552
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49107,0.00919218611666978,0.00891233905254044,-0.00827599842630948,0.026660370659649,0.302365827510174
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,45586,-0.00819117718602143,0.00752271006784009,-0.022935688918988,0.00655333454694515,0.276231688385679
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,45418,0.0152063915576038,0.0257772080213967,-0.0353169361643337,0.0657297192795413,0.55525507524494
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,45408,0.02405011183123,0.0277346569414809,-0.0303098157740726,0.0784100394365327,0.385872580205384
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,45438,0.00753034756646315,0.0114632899424368,-0.014937700720713,0.0299983958536393,0.511248219364292
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,45431,0.00667833954088596,0.0155869029563267,-0.0238719902535143,0.0372286693352862,0.66832309590258
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,45467,0.00931042279445903,0.012530683043022,-0.0152497159698641,0.0338705615587822,0.457486352658377
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,45431,0.00556020706048412,0.0140390925572858,-0.0219564143517961,0.0330768284727644,0.692072062025245
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,45424,0.0215491142777622,0.0140901308335505,-0.00606754215599684,0.0491657707115212,0.126190635684678
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,45443,-0.00990927541281877,0.0115157011028592,-0.0324800495744228,0.0126614987487853,0.389525480495886
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,45462,0.0174547987240639,0.0135845622343535,-0.00917094325526898,0.0440805407033968,0.198845661109196
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,45636,0.0068234041550152,0.00636892716442182,-0.00565969308725157,0.019306501397282,0.284023997753417
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,45525,0.0233461952226699,0.0087347408062472,0.00622610324242541,0.0404662872029144,0.00752963249424855
EPHA2,Ephrin type-A receptor 2,Mental health,X20127.Neuroticism score,46725,0.133716302149177,0.0371432737341234,0.0609154856302948,0.206517118668058,0.000319078530793471
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36480,-0.0617805996570719,0.058386905695186,-0.176218934819636,0.0526577355054927,0.290033941061408
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X20161.Pack years of smoking,36726,0.0229828470854275,0.00440510070871441,0.0143488496963473,0.0316168444745078,1.86363605993239e-07
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36726,0.0232033548781066,0.00455248012575794,0.0142804938316211,0.0321262159245922,3.5373597587905e-07
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20191.Fluid intelligence score,34163,-0.0897239114561999,0.0746888686723045,-0.236114094053917,0.0566662711415169,0.229691343360615
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34164,-0.078705193323843,0.0769675637248708,-0.22956161822459,0.0721512315769039,0.306558191720736
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20240.Maximum digits remembered correctly,33546,-0.121069375428855,0.0815428960304588,-0.280893451648554,0.0387547007908444,0.137687296883768
EPHA2,Ephrin type-A receptor 2,Physical measures,X20255.Spirometry QC measure,45662,0.0359844176072048,0.0471949069919122,-0.0565176000969431,0.128486435311353,0.445794039981934
EPHA2,Ephrin type-A receptor 2,Eye measures,X20261.avMSE,34163,0.00371952474411703,0.0048974817624605,-0.00587953951030556,0.0133185889985396,0.447603296575586
EPHA2,Ephrin type-A receptor 2,Eye measures,X20262.Myopia diagnosis,34163,-0.0706272891917091,0.0930940549527046,-0.25309163689901,0.111837058515592,0.44808840370624
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X20280.Glucose-lactate,42094,0.00921633993016938,0.0033166907344107,0.00271562609072441,0.0157170537696143,0.00546430879137175
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,42120,0.0113717891827975,0.00340259382062027,0.00470270529438173,0.0180408730712132,0.000833846784393854
EPHA2,Ephrin type-A receptor 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,36164,-0.00879299638255456,0.0208524506949452,-0.0496637997446471,0.032077806979538,0.673273885213475
EPHA2,Ephrin type-A receptor 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,36164,-0.0625542151970917,0.0390479103307485,-0.139088119445359,0.0139796890511754,0.109203966803246
EPHA2,Ephrin type-A receptor 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),36165,-0.0220279340579353,0.0661449990736548,-0.151672132242299,0.107616264126428,0.739125475496743
EPHA2,Ephrin type-A receptor 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),36165,-0.0100403911087995,0.0191418378656719,-0.0475583933255164,0.0274776111079175,0.599929438790743
EPHA2,Ephrin type-A receptor 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),36165,-0.0509877819263195,0.0405748938691859,-0.130514573909924,0.0285390100572849,0.208928386091949
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,36166,-0.0320480000160991,0.0511271425324025,-0.132257199379608,0.0681611993474098,0.530791543220145
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,36166,-0.0454731439037862,0.0311877207152838,-0.106601076505742,0.0156547886981699,0.144872796480876
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,36166,0.025649839234447,0.0375895446999323,-0.0480256683774203,0.0993253468463142,0.495030017277652
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,36166,-0.0124815942350136,0.0582043701693779,-0.126562159766994,0.101598971296967,0.830206885981894
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,36166,-0.0976273091637461,0.0683201408158763,-0.231534785162864,0.0362801668353715,0.1530581715236
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,36166,0.0621891897911551,0.0413440513237065,-0.0188451508033096,0.14322353038562,0.132578487388331
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,36166,-0.0930947926395829,0.0707815365361813,-0.231826604250498,0.0456370189713325,0.188472107783949
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,36166,-0.0616478407613558,0.0476363286437215,-0.15501504490305,0.0317193633803383,0.195661654293796
EPHA2,Ephrin type-A receptor 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),36166,-0.0559845720567157,0.0671596521542472,-0.18761749027904,0.0756483461656088,0.404532582262123
EPHA2,Ephrin type-A receptor 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),36166,-0.0179585421135501,0.0257687652051722,-0.0684653219156875,0.0325482376885874,0.485881578487417
EPHA2,Ephrin type-A receptor 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),36166,-0.0357159191437245,0.0484360220460208,-0.130650522353925,0.0592186840664764,0.460914035356851
EPHA2,Ephrin type-A receptor 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,36167,0.0758149300670331,0.086740365328863,-0.0941961859775384,0.245826046111605,0.382124178431143
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20600.Liking for adding salt to foods,35994,-0.0497421441909265,0.067961515051032,-0.182946713690949,0.0834624253090963,0.464244881379414
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20601.Liking for aniseed,35994,-0.00316582821191997,0.0676782889891563,-0.135815274630666,0.129483618206826,0.962691854256361
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20602.Liking for apple juice,35994,0.221772352430948,0.0678512947054445,0.088783814808277,0.35476089005362,0.00108654824438848
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20603.Liking for apples,35994,0.0182369754299072,0.0690839077104849,-0.117167483682643,0.153641434542458,0.791801048230255
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20604.Liking for asparagus,35994,-0.391597975469921,0.068359860686798,-0.525583302416045,-0.257612648523797,1.05671305932838e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20605.Liking for aubergine,35994,-0.449176720328491,0.0670322000825003,-0.580559832490191,-0.31779360816679,2.23740999333305e-11
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20606.Liking for avocados,35994,-0.375598882808972,0.0682194951933554,-0.509309093387949,-0.241888672229995,3.81065098735317e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20607.Liking for bacon,35994,-0.113160071637977,0.0677254288587355,-0.245901912201099,0.0195817689251444,0.0947943576449933
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20608.Liking for baked or steamed fish,35994,-0.284812630838275,0.0680258201419591,-0.418143238316514,-0.151482023360035,2.86450351329076e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20609.Liking for bananas,35994,0.141289641590793,0.0705774158418967,0.00295790654067535,0.27962137664091,0.0453341026543512
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35994,-0.323517717666313,0.0671513704477719,-0.455134403743945,-0.19190103158868,1.48345241184345e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20611.Liking for beef steak,35994,-0.22753483682572,0.068013132871336,-0.360840577253539,-0.0942290963979018,0.00082593375886896
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20612.Liking for beetroot,35994,-0.0236039212540764,0.068604710871775,-0.158069154562755,0.110861312054603,0.730814179355108
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20613.Liking for bell pepper,35994,-0.214710483215904,0.0677885475464969,-0.347576036407038,-0.0818449300247702,0.0015451310971362
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20614.Liking for bicycling,35994,-0.137432733811114,0.0670642361184395,-0.268878636603256,-0.00598683101897265,0.0404740492211988
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20615.Liking for biscuits,35994,0.313983495744329,0.0685732840090384,0.179579859086614,0.448387132402045,4.7597976449983e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20616.Liking for bitter foods,35994,-0.274347418165552,0.0672398718785525,-0.406137567047515,-0.142557269283589,4.55259113681901e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20617.Liking for bitter or ale,35994,-0.469137483852664,0.0684601390926733,-0.603319356474304,-0.334955611231024,7.88313772899047e-12
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20618.Liking for black olives,35994,-0.489283733639045,0.0676785471915681,-0.621933686134518,-0.356633781143571,5.3773003869582e-13
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20619.Liking for black pepper,35994,-0.222450184762856,0.0678134476537004,-0.355364542164109,-0.0895358273616031,0.00104210148119815
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20620.Liking for blue cheese,35994,-0.300798756485997,0.0670570068585781,-0.432230489928811,-0.169367023043184,7.38654820200265e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20621.Liking for bolognese sauce,35994,-0.253777632155682,0.067697078745977,-0.386463906497797,-0.121091357813567,0.000179212967981616
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20622.Liking for broad beans,35994,-0.237877156363295,0.0673872025128909,-0.369956073288561,-0.105798239438029,0.000418305279633107
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20623.Liking for broccoli,35994,-0.282741642087165,0.0694343917796366,-0.418833049975253,-0.146650234199077,4.71269017284467e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20624.Liking for brown rice,35994,-0.127141591551714,0.0666167466928238,-0.257710415069648,0.00342723196622088,0.0563618967849649
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20625.Liking for brussel sprouts,35994,-0.153040293712037,0.0675546400694655,-0.285447388248189,-0.0206331991758845,0.0235176769840581
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20626.Liking for burgers (meat),35994,-0.0363108926458701,0.067314054151963,-0.168246438783718,0.0956246534919773,0.589611227443236
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20627.Liking for burn of spicy foods,35994,-0.353169792144721,0.0676484311033695,-0.485760717107325,-0.220578867182117,1.83573308061232e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20628.Liking for butter on bread,35994,0.0789351375175329,0.0687567630296151,-0.0558281180205127,0.213698393055579,0.250994751888211
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20629.Liking for butternut squash,35994,-0.274981097138608,0.0667863749138469,-0.405882391969748,-0.144079802307468,3.87841634979607e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20630.Liking for cabbage,35994,-0.0182631976272426,0.0681672407921766,-0.151870989579909,0.115344594325424,0.788770949731735
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20631.Liking for cake,35994,0.368961089803291,0.0675022225912786,0.236656733524385,0.501265446082197,4.76907687190994e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20632.Liking for cake icing,35994,0.237644728412312,0.0665295860150812,0.107246739822753,0.368042717001871,0.000356697595299426
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20633.Liking for capers,35994,-0.500598560899478,0.0665023622925003,-0.630943190992779,-0.370253930806178,5.83990253332802e-14
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20634.Liking for cauliflower,35994,-0.1173703535209,0.0688426995185943,-0.252302044577344,0.0175613375355451,0.0882576349173387
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20635.Liking for cereal or granola bar,35994,0.115058792925553,0.0670869974241885,-0.0164317220258565,0.246549307876962,0.0863782971135216
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20636.Liking for cheesecake,35994,0.183823617319537,0.0673953588210761,0.0517287140302278,0.315918520608846,0.00639722833551447
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20637.Liking for cherries,35994,-0.229650490801848,0.072668683439974,-0.372081110344197,-0.087219871259499,0.00158331646286735
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20638.Liking for chicken,35994,-0.070761811927946,0.0712576057998015,-0.210426719295557,0.068903095439665,0.32072475493381
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20639.Liking for chilli pepper,35994,-0.466247384350213,0.0675881410479085,-0.598720140804113,-0.333774627896312,5.73555034990121e-12
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20640.Liking for chips or french fries,35994,0.086156824484124,0.068325975752921,-0.0477620879916011,0.220075736959849,0.207363929149067
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20641.Liking for cigarette smoking,35994,0.0220056298832503,0.115362997061144,-0.204105844356592,0.248117104123092,0.848726226924805
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20642.Liking for cod,35994,-0.158331266715977,0.0697093863438749,-0.294961663949971,-0.0217008694819818,0.0231596890901091
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20643.Liking for coffee with sugar,35994,0.195697738294795,0.0727071501349514,0.0531917240302903,0.3382037525593,0.00712868656605914
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20644.Liking for coffee without sugar,35994,-0.277619292647929,0.0685755232689205,-0.412027318255014,-0.143211267040845,5.21481584666115e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20645.Liking for coriander,35994,-0.350152417774962,0.0668724697042014,-0.481222458395197,-0.219082377154727,1.68909328698367e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20646.Liking for corn flakes,35994,0.318018250450241,0.0680297814329755,0.184679878841609,0.451356622058873,3.00079197336855e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20647.Liking for cream,35994,0.120425180107479,0.0671701645703982,-0.0112283424505016,0.252078702665459,0.0730434230002
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20648.Liking for croissant,35994,0.0606134500838792,0.0671107495800771,-0.0709236190930719,0.19215051926083,0.366459533409646
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20649.Liking for cucumber,35994,-0.0894923198408325,0.0681797465070303,-0.223124622994612,0.0441399833129468,0.189364181515431
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20650.Liking for curry,35994,-0.307979182802701,0.0678471985248346,-0.440959691911377,-0.174998673694025,5.74124074593625e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20651.Liking for dairy products,35994,0.0985691064488088,0.0691538888381376,-0.0369725156739408,0.234110728571558,0.154099459619211
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20652.Liking for dark chocolate,35994,-0.180432115553411,0.0678182856736035,-0.313355955473674,-0.0475082756331485,0.00782027796223421
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35994,0.162951983412358,0.0706362509356451,0.024504931578494,0.301399035246223,0.0210893781346726
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20654.Liking for dried fruit,35994,-0.0299673853393236,0.0676202781595398,-0.162503130532022,0.102568359853374,0.657655752396162
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20655.Liking for eggs,35994,-0.11633123774921,0.0697510830288119,-0.253043360485681,0.0203808849872616,0.095400454915866
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20656.Liking for exercising alone,35994,-0.217007914191627,0.0674753006176834,-0.349259503402287,-0.0847563249809677,0.00130550462735401
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20657.Liking for exercising with others,35994,-0.108424796930129,0.0668784373097356,-0.239506534057211,0.0226569401969527,0.10501645130747
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35994,-0.428736051385754,0.0679918062440427,-0.561999991624077,-0.29547211114743,3.04894841487547e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20659.Liking for fatty foods,35994,-0.0769939524664447,0.0670018502250425,-0.208317578907528,0.0543296739746385,0.250542134319374
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20660.Liking for fresh tomatoes,35994,-0.150454128814252,0.0727231536657418,-0.292991509999106,-0.00791674762939826,0.0385968422302894
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20661.Liking for fried chicken,35994,-0.0754557934257798,0.0669838473807963,-0.206744134292141,0.055832547440581,0.260003285342505
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20662.Liking for fried or battered fish,35994,0.0396464613566186,0.0674798892316095,-0.0926141215373361,0.171907044250573,0.556867322015799
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20663.Liking for fruit,35994,-0.0062879959892483,0.0767959118835295,-0.156807983280966,0.144231991302469,0.934745103388133
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20664.Liking for garlic,35994,-0.408846035744843,0.0675816066304531,-0.541305984740531,-0.276386086749155,1.52863262388816e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20665.Liking for gherkins,35994,-0.233511841266218,0.0667533216437712,-0.364348351688009,-0.102675330844426,0.000471532339199984
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20666.Liking for globe artichoke,35994,-0.416008173809843,0.0674036542790446,-0.54811933619677,-0.283897011422915,7.13623739922824e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20667.Liking for goat's cheese,35994,-0.369773714075065,0.0669368636812044,-0.500969966890225,-0.238577461259904,3.43226383606454e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20668.Liking for going to a cafe,35994,0.156269930074382,0.0676026962158904,0.0237686454912368,0.288771214657527,0.0208298965476638
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20669.Liking for going to the gym,35994,-0.224843561166447,0.0668208285832859,-0.355812385189688,-0.0938747371432068,0.000770034164334989
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20670.Liking for going to the pub,35994,-0.463546572226004,0.0674226148000426,-0.595694897234087,-0.33139824721792,6.73974554701901e-12
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20671.Liking for grapefruit,35994,0.0249945141478989,0.067422195351457,-0.107152988740957,0.157142017036755,0.710860330002413
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20672.Liking for green olives,35994,-0.520078449102191,0.0671685768622409,-0.651728859752184,-0.388428038452199,1.11335240959378e-14
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20673.Liking for haddock,35994,-0.326256884480966,0.0700558580305161,-0.463566366220778,-0.188947402741154,3.26802039864249e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20674.Liking for ham,35994,-0.0710156036487882,0.0683450470784945,-0.204971895922637,0.0629406886250611,0.298807028083484
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20675.Liking for hard cheese,35994,-0.0280030874638782,0.0686227278185129,-0.162503633988164,0.106497459060407,0.683232892640186
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20676.Liking for herring,35994,-0.335306190286222,0.0664484506624373,-0.465545153584599,-0.205067226987845,4.62612298670873e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20677.Liking for honey,35994,0.0198314721324328,0.067388342894235,-0.112249679940268,0.151912624205133,0.76854806636974
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35994,-0.399188172367072,0.0666936423246568,-0.529907711323399,-0.268468633410744,2.26853086648919e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20679.Liking for ice cream,35994,0.232126342696251,0.0680746921301336,0.0986999461211895,0.365552739271313,0.00065370526026013
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20680.Liking for jam,35994,0.200200296618266,0.0679955966180094,0.0669289272469681,0.333471665989565,0.00324769925483784
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20681.Liking for kiwi fruit,35994,-0.0651150158540974,0.0686075649708903,-0.199585843197042,0.0693558114888476,0.342606670787002
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20682.Liking for lager,35994,-0.194763679520434,0.0676983805170237,-0.327452505333801,-0.0620748537070679,0.00402812556767688
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20683.Liking for lamb,35994,-0.21031027380798,0.0686764368266874,-0.344916089988287,-0.0757044576276724,0.00220476712996259
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20684.Liking for lemons,35994,-0.183143364051639,0.0674438123653679,-0.315333236287761,-0.0509534918155182,0.006634408727009
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20685.Liking for lentils or beans,35994,-0.167649571722015,0.0684112676607536,-0.301735656337092,-0.0335634871069384,0.0142863467902958
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20686.Liking for liver,35994,-0.377390593420151,0.0675022406126723,-0.509694985020989,-0.245086201819313,2.34827716488917e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20687.Liking for mackerel,35994,-0.320710726722296,0.0673053183288136,-0.452629150646771,-0.188792302797821,1.92767608131676e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20688.Liking for marzipan,35994,0.0961079918807297,0.067062566437643,-0.0353346383370505,0.22755062209851,0.151872619595335
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20689.Liking for mayonnaise,35994,-0.0628908720116688,0.0673439483602834,-0.194885010797824,0.0691032667744867,0.350401255365438
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20690.Liking for melon,35994,0.0705238482661787,0.0705811161758425,-0.0678151394384726,0.20886283597083,0.317738927083591
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20691.Liking for milk chocolate,35994,0.302794746980526,0.0673835894948192,0.17072291157068,0.434866582390372,7.11905635618027e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20692.Liking for mushrooms,35994,-0.19797128149651,0.0694187514936772,-0.334032034424118,-0.0619105285689031,0.00435979629817678
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20694.Liking for orange juice,35994,0.196808376014903,0.0677265721347036,0.0640642946308839,0.329552457398922,0.00367351833486666
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20695.Liking for oranges,35994,-0.00555614340151811,0.0697665363922742,-0.142298554730376,0.131186267927339,0.936526651969886
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20696.Liking for pasta,35994,-0.134900433596966,0.0684589287205377,-0.26907993388922,-0.000720933304712207,0.0488181151044243
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20697.Liking for pears,35994,0.105866485753051,0.0696327530203108,-0.0306137101667581,0.24234668167286,0.128468399823404
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20698.Liking for pizza,35994,-0.0949549898586103,0.0672213386526384,-0.226708813617782,0.036798833900561,0.157827392133434
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20699.Liking for plain yogurt,35994,-0.315183646392185,0.0673815890902486,-0.447251561009072,-0.183115731775298,2.9587924876647e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20700.Liking for plums,35994,0.0523342271510701,0.0698909682888681,-0.0846520706951114,0.189320524997252,0.454004813801034
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20701.Liking for pollock,35994,-0.266329371515845,0.0661594876626599,-0.396001967334659,-0.136656775697032,5.74567837552988e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20702.Liking for pork chop,35994,-0.199384888225483,0.0673440946185043,-0.331379313677751,-0.0673904627732142,0.00308013866791597
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20703.Liking for porridge,35994,-0.024384813228764,0.0682124205766565,-0.158081157559011,0.109311531101483,0.720741003109282
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20704.Liking for potato crisps,35994,0.144877026970861,0.0678195965592285,0.0119506177147735,0.277803436226949,0.0326977982941207
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20705.Liking for potatoes,35994,0.128521088455844,0.0688035646741039,-0.0063338983053999,0.263376075217087,0.0618131432966777
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20706.Liking for prawns,35994,-0.371466171217112,0.0681050420153992,-0.504952053567294,-0.237980288866929,5.08957080359371e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20707.Liking for raw carrots,35994,-0.0373117621281481,0.0678348215455803,-0.170268012357486,0.0956444881011894,0.582311070376527
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20708.Liking for red meat,35994,-0.198237948037383,0.0678542394975321,-0.331232257452546,-0.06524363862222,0.00349468542030205
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20709.Liking for red wine,35994,-0.542477687190156,0.0672600334468189,-0.674307352745921,-0.410648021634391,8.563582766518e-16
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35994,0.158964219075381,0.0697816720480618,0.0221921418611798,0.295736296289582,0.0227561668776364
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20711.Liking for roast chicken,35994,-0.137793335691258,0.0706336125022525,-0.276235216195673,0.000648544813156349,0.0511197499963989
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20712.Liking for salad dressing,35994,-0.185158338216311,0.0675290149343445,-0.317515207487627,-0.0528014689449961,0.00612434536703356
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20713.Liking for salad leaves,35994,-0.196627671786754,0.0684254081186503,-0.330741471699309,-0.0625138718741999,0.00407073902251952
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20714.Liking for salami,35994,-0.362681400462552,0.0670696672401358,-0.494137948253218,-0.231224852671886,6.60763219870774e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20715.Liking for salmon,35994,-0.374125227326305,0.0708209021357256,-0.512934195512327,-0.235316259140283,1.3125451038786e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20716.Liking for salty foods,35994,-0.0139110224047726,0.0668591425212791,-0.144954941746479,0.117132896936934,0.835184747356675
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20717.Liking for salty pretzels,35994,-0.1091398349964,0.0673892965986618,-0.241222856329777,0.0229431863369775,0.105377006975142
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20718.Liking for sardines,35994,-0.26065685344778,0.0672412997769725,-0.392449801010646,-0.128863905884913,0.000106995119162989
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20719.Liking for sausages (meat),35994,-0.0920088912709129,0.0675899348208832,-0.224485163519844,0.0404673809780181,0.173470082878798
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20720.Liking for savoury biscuits,35994,0.0732812332197821,0.0679346847973836,-0.0598707489830897,0.206433215422654,0.280759215305862
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35994,-0.509685054769075,0.0670529425972666,-0.641108822259718,-0.378261287278433,3.32845763303784e-14
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20722.Liking for skimmed milk,35994,-0.183314895058813,0.0670556878172183,-0.314744043180561,-0.0518857469370654,0.00627758213174035
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20723.Liking for smoked fish,35994,-0.339061311712276,0.0673364535163304,-0.471040760604284,-0.207081862820269,4.89316893978582e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20724.Liking for soft cheese,35994,-0.170900220042627,0.0671433268615451,-0.302501140691255,-0.0392992993939985,0.0109401661722681
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20725.Liking for soy sauce,35994,-0.346901732887212,0.0676433175007598,-0.479482635188701,-0.214320830585723,3.00309462859811e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20726.Liking for soya milk,35994,-0.0846768397903196,0.067410046218638,-0.21680053037885,0.0474468507982109,0.209106360522812
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20727.Liking for spicy foods,35994,-0.30753180553887,0.0674341517043738,-0.439702742879443,-0.175360868198298,5.19333986448477e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20728.Liking for spinach,35994,-0.346032663703905,0.0684434230570578,-0.480181772895738,-0.211883554512071,4.39931400662391e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20729.Liking for spirits,35994,-0.414146655435222,0.0673832878034302,-0.546217899529946,-0.282075411340499,8.38904062802868e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20730.Liking for strawberries,35994,0.0429229211931099,0.074566741809303,-0.103227892753124,0.189073735139344,0.564883759051332
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35994,0.109009356672135,0.0692861221362105,-0.0267914427148372,0.244810156059108,0.115690940620326
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20732.Liking for sweet foods,35994,0.405086173384445,0.0673601412781472,0.273060296479276,0.537112050289614,1.90704872973307e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20733.Liking for taking the stairs,35994,-0.318597954814012,0.0683613910151112,-0.45258628120363,-0.184609628424394,3.2146786032934e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20734.Liking for tea with sugar,35994,0.245663834649493,0.0810028893307404,0.0868981715612418,0.404429497737744,0.00243228354207628
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20735.Liking for tea without sugar,35994,-0.135789362214935,0.0703023467847862,-0.273581961913116,0.00200323748324557,0.0534621425735341
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20736.Liking for tomato ketchup,35994,0.0614209429925559,0.0664277249975166,-0.0687773980025767,0.191619283987689,0.355192230098116
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20737.Liking for tinned tuna,35994,-0.210620899103182,0.0670640744613827,-0.342066485047492,-0.0791753131588716,0.00169330571432542
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20738.Liking for turnip (white),35994,-0.0854741846182741,0.0668949982508479,-0.216588381189936,0.0456400119533878,0.201386007186838
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20739.Liking for vegetables,35994,-0.113850150082076,0.0743729858012944,-0.259621202252613,0.0319209020884611,0.125865462996518
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20740.Liking for vinegar,35994,-0.167827443695011,0.0671741148242919,-0.299488708750623,-0.0361661786393985,0.0124991773153802
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20741.Liking for watching television,35994,0.269174077941414,0.0688131936013147,0.134300218482838,0.404047937399991,9.25565977266254e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20742.Liking for whisky,35994,-0.232954976194576,0.0696338960237324,-0.369437412401092,-0.0964725399880604,0.000826021292485508
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20743.Liking for white bread,35994,0.269242344120296,0.0663044348614826,0.13928565179179,0.399199036448802,4.94761688721638e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20744.Liking for white rice,35994,0.0518166085256253,0.0677427254229265,-0.0809591333033106,0.184592350354561,0.444355933879022
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20745.Liking for white wine,35994,-0.465842397302401,0.0674749980711743,-0.598093393521903,-0.333591401082899,5.51667141987429e-12
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35994,-0.13515052399112,0.0686145421282891,-0.269635026562567,-0.000666021419673257,0.0489125720128715
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20747.Liking for whole milk,35994,0.0985293836545917,0.0668811592556736,-0.0325576884865285,0.229616455795712,0.140743220605323
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20748.Liking for wholemeal bread,35994,-0.0842864722795082,0.0706194800514203,-0.222700653180292,0.0541277086212756,0.232703539140737
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20749.Liking for working up a sweat,35994,-0.290461042115631,0.0679724956361552,-0.423687133562495,-0.157234950668766,1.95307594146171e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X21001.Body mass index (BMI),51408,-0.143880268459235,0.01133277314433,-0.166092503822121,-0.121668033096348,8.36071962985344e-37
EPHA2,Ephrin type-A receptor 2,Physical measures,X21002.Weight,51427,0.00517982471424837,0.00611917068025233,-0.00681374981904619,0.0171733992475429,0.39728783877591
EPHA2,Ephrin type-A receptor 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,36794,-0.000783062749137361,0.00411816200814918,-0.00885466028510975,0.00728853478683503,0.849197764175402
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,35794,0.0956099540142509,0.0717739433355957,-0.0450669749235166,0.236286882952018,0.182873891074026
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,35812,0.0445418708421549,0.0737794975607048,-0.100065944376827,0.189149686061136,0.546053106438385
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,35814,-0.0946172169596869,0.072864530592413,-0.237431696920816,0.0481972630014426,0.194148462241698
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21040.Satisfaction with bowel habits,35770,0.115991743365887,0.0667161981598342,-0.0147720050273879,0.246755491759162,0.0821547532531075
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,35754,0.15783752053206,0.0718703609826219,0.016971613006121,0.298703428057999,0.0281167044837087
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21042.Greatest number of times bowels opened per day,35773,-0.0192266402958674,0.0713013393605254,-0.158977265442497,0.120523984850762,0.787435461845632
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21043.Least number of times bowels opened per week,35706,-0.0180241949011916,0.0728521786010919,-0.160814464959332,0.124766075156949,0.80460046397308
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21044.Average number of times bowels opened per day,35737,0.0267520725640851,0.0817087721115533,-0.133397120774559,0.18690126590273,0.743370110043198
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,35818,-0.091899519884329,0.0721971111557631,-0.233405857749625,0.0496068179809667,0.203099108077091
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,35813,-0.114646930153801,0.0730988059905546,-0.257920589895288,0.0286267295876865,0.116839566970393
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32675,0.0347098094112042,0.13295235604922,-0.225876808445267,0.295296427267676,0.794054334933301
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,35816,0.0242307164638137,0.0840694164632212,-0.1405453398041,0.189006772731727,0.773185274862019
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,35815,-0.0828748527465014,0.108693182599572,-0.295913490641662,0.130163785148659,0.445809112429263
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,35813,-0.187665581373131,0.0834572805111317,-0.35124185117495,-0.0240893115713134,0.0245680184371471
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,35813,-0.494520676774956,0.20111356668664,-0.88870326748077,-0.100338086069143,0.0139612691732573
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,35819,0.116923966806184,0.0868601411882871,-0.0533219099228583,0.287169843535227,0.178310650729646
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,35815,-0.347966387535826,0.0790415407433779,-0.502887807392847,-0.193044967678805,1.08780927974111e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,35664,0.137196981330229,0.07662316196946,-0.0129844161299125,0.287378378790371,0.0734135900626103
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,35809,-0.0518274376930688,0.0729186581175244,-0.194748007603417,0.091093132217279,0.477259969436516
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,35815,-0.33743668843846,0.112983829205807,-0.558884993681843,-0.115988383195078,0.00283138511862407
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,35820,-0.257983683251397,0.0740196487016301,-0.403062194706592,-0.112905171796202,0.000494694207511199
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,35819,0.0126835627957072,0.07332962758567,-0.131042507272206,0.15640963286362,0.862683111330768
EPHA2,Ephrin type-A receptor 2,Working and living environment,X21100.Water hardness (USGS classification),51376,-0.017895481045022,0.0350606109769188,-0.0866142785597828,0.0508233164697389,0.6097654443428
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2139.Age first had sexual intercourse,47711,-0.00460181729658189,0.00276894955238239,-0.0100289584192514,0.000825323826087596,0.0965425088116192
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2149.Lifetime number of sexual partners,46565,-0.132880500387124,0.0406787033983032,-0.212610759047798,-0.0531502417264493,0.00109063646030738
EPHA2,Ephrin type-A receptor 2,Physical activities,X22032.IPAQ activity group,46574,-0.267288145385681,0.0403829695136648,-0.346438765632465,-0.188137525138898,3.72626456073319e-11
EPHA2,Ephrin type-A receptor 2,Physical activities,X22033.Summed days activity,47057,-0.0272669742031273,0.00273117269351734,-0.0326200726824213,-0.0219138757238333,2.07082226911081e-23
EPHA2,Ephrin type-A receptor 2,Physical activities,X22034.Summed minutes activity,46574,-0.018289307887249,0.00270382625216804,-0.0235888073414984,-0.0129898084329997,1.38288106311783e-11
EPHA2,Ephrin type-A receptor 2,Physical activities,X22037.MET minutes per week for walking,45611,-0.0165896687131784,0.00287430991747315,-0.0222233161514257,-0.010956021274931,7.98889730527842e-09
EPHA2,Ephrin type-A receptor 2,Physical activities,X22038.MET minutes per week for moderate activity,46574,-0.0153423272154341,0.00264209325782841,-0.0205208300007778,-0.0101638244300905,6.4756601577086e-09
EPHA2,Ephrin type-A receptor 2,Physical activities,X22039.MET minutes per week for vigorous activity,46574,-0.302094651523187,0.040749706904566,-0.381964077056137,-0.222225225990238,1.28739838989588e-13
EPHA2,Ephrin type-A receptor 2,Physical activities,X22040.Summed MET minutes per week for all activity,45611,-0.0186991525472858,0.00279207438658351,-0.0241716183449895,-0.0132266867495822,2.19305371829079e-11
EPHA2,Ephrin type-A receptor 2,Eye measures,X2217.Age started wearing glasses or contact lenses,49617,-0.00371181350804577,0.00230402282654637,-0.00822769824807665,0.000804071231985106,0.107192079221477
EPHA2,Ephrin type-A receptor 2,Working and living environment,X22501.Year ended full time education,33963,-0.0263168638343974,0.01060821561711,-0.047108966443933,-0.00552476122486172,0.0131430127493497
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X22506.Tobacco smoking,33931,-0.0636851785322285,0.171234036750743,-0.399303890563686,0.271933533499229,0.709969858375238
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50242,-0.193629606412119,0.136735677481529,-0.461631534275915,0.0743723214516772,0.156764851354291
EPHA2,Ephrin type-A receptor 2,Physical measures,X23098.Weight,50957,0.00835359481316419,0.0061467908698637,-0.00369411529176866,0.020401304918097,0.174155206396251
EPHA2,Ephrin type-A receptor 2,Physical measures,X23099.Body fat percentage,50950,-0.0521724326355994,0.0058266505553693,-0.0635926677241232,-0.0407521975470755,3.6937305285481e-19
EPHA2,Ephrin type-A receptor 2,Physical measures,X23100.Whole body fat mass,50934,-0.0328863903466983,0.00574793621490415,-0.0441523453279104,-0.0216204353654861,1.07021709096688e-08
EPHA2,Ephrin type-A receptor 2,Physical measures,X23101.Whole body fat-free mass,50956,0.0288005277458072,0.00500013479045047,0.0190002635565242,0.0386007919350901,8.52724485872088e-09
EPHA2,Ephrin type-A receptor 2,Physical measures,X23102.Whole body water mass,50957,0.0290161541071003,0.00501499191906015,0.0191867699457424,0.0388455382684582,7.31217559168418e-09
EPHA2,Ephrin type-A receptor 2,Physical measures,X23104.Body mass index (BMI),50957,-0.128940686954383,0.0112852572727514,-0.151059791208976,-0.10682158269979,3.79747068505139e-30
EPHA2,Ephrin type-A receptor 2,Physical measures,X23105.Basal metabolic rate,50957,0.0269752182104895,0.00533990752596997,0.0165089994595883,0.0374414369613906,4.41605331559642e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,X23106.Impedance of whole body,50954,-0.0221944598050652,0.00408703169889366,-0.0302050419348968,-0.0141838776752336,5.68110168838251e-08
EPHA2,Ephrin type-A receptor 2,Physical measures,X23107.Impedance of leg (right),50957,-0.0445528192533425,0.00328730078260284,-0.0509959287872441,-0.0381097097194409,1.12275816021442e-41
EPHA2,Ephrin type-A receptor 2,Physical measures,X23108.Impedance of leg (left),50957,-0.0453178883969442,0.00326848621313634,-0.0517241213746915,-0.038911655419197,1.57900436698723e-43
EPHA2,Ephrin type-A receptor 2,Physical measures,X23109.Impedance of arm (right),50954,0.0197533794549181,0.00403596241240997,0.0118428931265946,0.0276638657832416,9.93410105334132e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,X23110.Impedance of arm (left),50957,0.0144956009459356,0.00405033436892811,0.0065569455828365,0.0224342563090347,0.000345839338588473
EPHA2,Ephrin type-A receptor 2,Physical measures,X23111.Leg fat percentage (right),50957,-0.115849211980784,0.00683063947893566,-0.129237265359497,-0.10246115860207,4.17619134784087e-64
EPHA2,Ephrin type-A receptor 2,Physical measures,X23112.Leg fat mass (right),50957,-0.0780224443518891,0.00751612944005727,-0.0927540580544013,-0.0632908306493768,3.47673171301108e-25
EPHA2,Ephrin type-A receptor 2,Physical measures,X23113.Leg fat-free mass (right),50956,0.0570220241966466,0.00508137582815996,0.0470625275734531,0.0669815208198401,3.83371267501009e-29
EPHA2,Ephrin type-A receptor 2,Physical measures,X23114.Leg predicted mass (right),50956,0.0568462232795913,0.00511156582677047,0.0468275542591211,0.0668648923000614,1.18328617890179e-28
EPHA2,Ephrin type-A receptor 2,Physical measures,X23115.Leg fat percentage (left),50954,-0.129214631220511,0.00717399883350583,-0.143275668934182,-0.115153593506839,5.27763838966911e-72
EPHA2,Ephrin type-A receptor 2,Physical measures,X23116.Leg fat mass (left),50954,-0.0860937241648896,0.00786956066524535,-0.101518063068771,-0.0706693852610087,8.75706052641175e-28
EPHA2,Ephrin type-A receptor 2,Physical measures,X23117.Leg fat-free mass (left),50953,0.0568249206148848,0.00534869366361714,0.0463414810341952,0.0673083601955744,2.67137326884372e-26
EPHA2,Ephrin type-A receptor 2,Physical measures,X23118.Leg predicted mass (left),50953,0.0573287048402268,0.00538222702316681,0.0467795398748199,0.0678778698056337,1.99372957934498e-26
EPHA2,Ephrin type-A receptor 2,Physical measures,X23119.Arm fat percentage (right),50953,-0.0119925640482786,0.00658325659318637,-0.0248957469709239,0.000910618874366671,0.0685178035125742
EPHA2,Ephrin type-A receptor 2,Physical measures,X23120.Arm fat mass (right),50951,-0.0146986252730474,0.00658887905594652,-0.0276128282227025,-0.00178442232339218,0.0257029848515588
EPHA2,Ephrin type-A receptor 2,Physical measures,X23121.Arm fat-free mass (right),50952,0.000957174458170759,0.00511503123103613,-0.00906828675466006,0.0109826356710016,0.851560656603644
EPHA2,Ephrin type-A receptor 2,Physical measures,X23122.Arm predicted mass (right),50952,0.000821371868425515,0.00512426391073413,-0.00922218539661338,0.0108649291334644,0.872653569538191
EPHA2,Ephrin type-A receptor 2,Physical measures,X23123.Arm fat percentage (left),50951,-0.0151214153304739,0.00673440956567884,-0.0283208580792044,-0.00192197258174332,0.0247527301071176
EPHA2,Ephrin type-A receptor 2,Physical measures,X23124.Arm fat mass (left),50951,-0.0193934863612096,0.00659656803258391,-0.032322759705074,-0.00646421301734509,0.00328625512094741
EPHA2,Ephrin type-A receptor 2,Physical measures,X23125.Arm fat-free mass (left),50951,0.00163062244296646,0.00521208058971591,-0.00858505551287672,0.0118463003988096,0.754394267592366
EPHA2,Ephrin type-A receptor 2,Physical measures,X23126.Arm predicted mass (left),50949,0.00297389335584988,0.00521982948096002,-0.00725697242683177,0.0132047591385315,0.56886673437944
EPHA2,Ephrin type-A receptor 2,Physical measures,X23127.Trunk fat percentage,50948,-0.0212342713116132,0.00417959640886729,-0.0294262802729931,-0.0130422623502333,3.79635715033842e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,X23128.Trunk fat mass,50948,-0.0174556031429745,0.00467723963698642,-0.0266229928314678,-0.00828821345448108,0.000190425454191217
EPHA2,Ephrin type-A receptor 2,Physical measures,X23129.Trunk fat-free mass,50947,0.0137468973816808,0.00451229663466195,0.00490279597774336,0.0225909987856182,0.00231768076539251
EPHA2,Ephrin type-A receptor 2,Physical measures,X23130.Trunk predicted mass,50944,0.0135951995932265,0.00452508963341184,0.00472602391173928,0.0224643752747137,0.00266404258941514
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23400.Total Cholesterol,42125,-0.0493263673226792,0.00330688023911403,-0.0558078525913427,-0.0428448820540157,6.70964939112485e-50
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42125,-0.0362148232763749,0.00322210407708719,-0.0425301472674658,-0.029899499285284,3.56166288038685e-29
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42125,-0.0271837087735663,0.00322448660354015,-0.033503702516505,-0.0208637150306276,3.80727474432101e-17
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23403.VLDL Cholesterol,42125,-0.00716001541615259,0.00328595252349349,-0.0136004823621998,-0.00071954847010536,0.0293513573507257
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,42125,-0.0439937067526523,0.00321239549197768,-0.0502900019169286,-0.0376974115883761,2.14885656628855e-42
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23405.LDL Cholesterol,42125,-0.0432430058167418,0.00322828057909451,-0.049570435751767,-0.0369155758817166,1.20567031172307e-40
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23406.HDL Cholesterol,42125,-0.0679199898734365,0.00368003180288856,-0.0751328522070981,-0.060707127539775,4.2581561089744e-75
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23407.Total Triglycerides,42125,0.0122059446018389,0.00354557149080502,0.00525662447986102,0.0191552647238167,0.000577998671381091
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23408.Triglycerides in VLDL,42125,0.00965036309296711,0.00353264643532436,0.00272637607973136,0.0165743501062029,0.00630813617346436
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23409.Triglycerides in LDL,42125,0.0132259517241468,0.00352029961454383,0.00632616447964086,0.0201257389686527,0.000172681338798753
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23410.Triglycerides in HDL,42125,0.0197371903250295,0.00347294430929638,0.0129302194788086,0.0265441611712504,1.35108600642395e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42125,-0.0480992039348037,0.00342711013722586,-0.0548163398037663,-0.041382068065841,2.01800576124402e-44
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23412.Phospholipids in VLDL,42125,0.00284872435157545,0.00339001775401441,-0.0037957104462928,0.00949315914944369,0.400740454660922
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23413.Phospholipids in LDL,42125,-0.0412552520734452,0.00321147087972644,-0.0475497349977091,-0.0349607691491814,1.53202193293442e-37
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23414.Phospholipids in HDL,42125,-0.0562535859062572,0.00366671724976079,-0.0634403517157883,-0.049066820096726,1.17064649731555e-52
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23415.Total Esterified Cholesterol,42125,-0.0527622547043753,0.00331941128902407,-0.0592683008308625,-0.0462562085778881,2.34069678936354e-56
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42125,-0.0103353014431984,0.00324747545576717,-0.0167003533365021,-0.00397024954989479,0.00146322204975237
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42125,-0.0412938693710831,0.00323408261817586,-0.0476326713027078,-0.0349550674394584,4.12641789720858e-37
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42125,-0.0693572296451373,0.00365963699411578,-0.0765301181536042,-0.0621843411366704,4.99424078519949e-79
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23419.Total Free Cholesterol,42125,-0.0402027661592059,0.00327818914923202,-0.0466280168917007,-0.0337775154267112,2.2019048177129e-34
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,42125,-0.00275108480389774,0.00335175024505362,-0.00932051528420283,0.00381834567640735,0.411780733896234
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23421.Free Cholesterol in LDL,42125,-0.04701610013012,0.00322984287181355,-0.0533465921588746,-0.0406856081013655,1.25854519630017e-47
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23422.Free Cholesterol in HDL,42125,-0.057800887324958,0.00372743725692013,-0.0651066643485215,-0.0504951103013946,9.49072781250181e-54
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42125,-0.037194149663934,0.00331023087855957,-0.0436822021859108,-0.0307060971419572,3.6990983220941e-29
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23424.Total Lipids in VLDL,42125,0.00363577966034797,0.00343462448769146,-0.00309608433552729,0.0103676436562232,0.289816859502291
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23425.Total Lipids in LDL,42125,-0.040460259841779,0.0032290534347494,-0.0467892045738878,-0.0341313151096701,8.25090205260643e-36
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23426.Total Lipids in HDL,42125,-0.0597876586234846,0.00368333251066871,-0.0670069903443953,-0.0525683269025739,1.138344985969e-58
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42125,-0.0714799984337884,0.00345369873001445,-0.0782492479446167,-0.0647107489229601,1.21392233592893e-93
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23428.Concentration of VLDL Particles,42125,0.000261785330315595,0.00334437227178342,-0.00629318432237991,0.0068167549830111,0.937609422804269
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23429.Concentration of LDL Particles,42125,-0.0255497623698264,0.00321620053469946,-0.0318535154178373,-0.0192460093218154,2.11750450062465e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23430.Concentration of HDL Particles,42125,-0.0711964559142325,0.00346180415166197,-0.0779815920514899,-0.064411319776975,1.65080509065014e-92
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42125,0.0050229908585781,0.0035986973021496,-0.00203045585363512,0.0120764375707913,0.162804624016977
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,42125,-0.0148664241173578,0.00343140901867681,-0.0215919857939643,-0.00814086244075123,1.48568577562174e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,42125,-0.0179882359275506,0.00384761729724563,-0.0255295658301521,-0.0104469060249492,2.96689631665984e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23434.Phosphoglycerides,42115,-0.0486188041406086,0.00349361174763299,-0.0554662831659693,-0.0417713251152479,1.03960515230427e-43
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42115,0.040197727548895,0.00367483259088282,0.0329950556707647,0.0474003994270253,9.96333956337611e-28
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23436.Total Cholines,42115,-0.0510852950566378,0.00349599068913297,-0.0579374368073384,-0.0442331533059371,5.63722686631876e-48
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23437.Phosphatidylcholines,42115,-0.048106489231423,0.00352607646487194,-0.055017599102572,-0.041195379360274,4.34376205545477e-42
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23438.Sphingomyelins,42115,-0.0512376206554236,0.00343381369243806,-0.0579678954926022,-0.044507345818245,6.21881231568297e-50
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23439.Apolipoprotein B,42125,-0.02437845279611,0.0032145965900199,-0.030679062112549,-0.018077843479671,3.58807977495041e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23440.Apolipoprotein A1,42125,-0.0619591657356059,0.00359041569422389,-0.0689963804962847,-0.054921950974927,5.44321940586018e-66
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42125,0.00712488349995855,0.00330331699414148,0.00065038219144124,0.0135993848084759,0.0310327927817704
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23442.Total Fatty Acids,42115,-0.0204073603549221,0.0034211014571887,-0.027112719211012,-0.0137020014988322,2.50810611620378e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23443.Degree of Unsaturation,42115,-0.0644091806285013,0.00344174488550584,-0.0711550006040928,-0.0576633606529099,3.96181798197465e-77
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,42115,-0.0562008301503398,0.00341493878944895,-0.0628941101776597,-0.0495075501230198,3.04321845746776e-60
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,42115,-0.0313416069681342,0.00336794431337158,-0.0379427778223425,-0.0247404361139259,1.54084146555681e-20
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42115,-0.0418927641275898,0.00340259548772263,-0.0485618512835261,-0.0352236769716534,1.22053390619645e-34
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42115,0.00590984933830766,0.00351242766888415,-0.000974508892705271,0.0127942075693206,0.092485617991223
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23448.Saturated Fatty Acids,42115,-0.0216371822808352,0.00342131193893009,-0.0283429536811382,-0.0149314108805322,2.62874271749948e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23449.Linoleic Acid,42115,-0.0159053257912725,0.00330784287517827,-0.0223886978266219,-0.00942195375592311,1.53882853936462e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23450.Docosahexaenoic Acid,42115,-0.0663269282935764,0.00340010853879449,-0.0729911410296136,-0.0596627155575392,1.50755178872998e-83
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42115,-0.0557743813483881,0.00338314391576593,-0.0624053434232893,-0.0491434192734869,1.91472770395498e-60
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42115,-0.00744369046749355,0.0036780324732021,-0.0146526341149697,-0.000234746820017429,0.0430088011417457
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42115,-0.0326065113206554,0.00362538118427546,-0.0397122584418353,-0.0255007641994755,2.71379568212098e-19
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42115,0.0581088621013003,0.0036466450432867,0.0509614378164584,0.0652562863861423,1.25535318221349e-56
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42115,-0.0126836134957314,0.00334222575551365,-0.0192343759765382,-0.00613285101492465,0.000148341310062949
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42115,0.00558665140474156,0.0035344083656286,-0.00134078899189049,0.0125140918013736,0.113983287228631
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42115,-0.0547858590257013,0.00338092177680053,-0.0614124657082303,-0.0481592523431722,1.76802081234809e-58
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42115,-0.0488918996234628,0.00366458375004376,-0.0560744837735486,-0.041709315473377,2.44622022083459e-40
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42115,0.0479841870447656,0.00335352156423086,0.0414112847788731,0.0545570893106581,4.34864789472091e-46
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23460.Alanine,42120,0.011045612979093,0.0033396583173649,0.00449988267705782,0.0175913432811282,0.000944205599358145
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23461.Glutamine,42083,-0.000134771424605661,0.00335014171158273,-0.00670104917930781,0.00643150633009648,0.967911520180684
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23462.Glycine,42110,0.0492497499175362,0.00353063117277678,0.0423297128188937,0.0561697870161787,6.61493930908444e-44
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23463.Histidine,42106,-0.00435921583377736,0.00329318771335374,-0.0108138637519507,0.00209543208439597,0.1856237870142
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42117,-0.0205819292306701,0.00348662684407586,-0.0274157178450587,-0.0137481406162814,3.65669802372104e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23465.Isoleucine,42122,-0.00368637287455063,0.00339581412425229,-0.0103421685580851,0.00296942280898386,0.277692265749637
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23466.Leucine,42122,-0.0190498428276754,0.00343612332279405,-0.0257846445403518,-0.0123150411149991,3.01446144793724e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23467.Valine,42117,-0.026489630358712,0.00351776717248311,-0.0333844540167789,-0.0195948067006451,5.40050908585829e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23468.Phenylalanine,42118,0.0303599030407226,0.00332271860472911,0.0238473745754535,0.0368724315059916,7.36237801800764e-20
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23469.Tyrosine,42109,-0.0161329259398516,0.00338755963013617,-0.0227725428149185,-0.00949330906478473,1.93379626071374e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23470.Glucose,42099,0.0076713524641487,0.00328818839535795,0.00122650320924713,0.0141162017190503,0.0196632875097014
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23471.Lactate,42102,0.0043576817118009,0.00330336249351317,-0.00211690877548492,0.0108322721990867,0.187137201820375
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23472.Pyruvate,42086,0.00838899938802331,0.00333632848402643,0.00184979555933151,0.0149282032167151,0.0119342164132922
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23473.Citrate,42123,0.0450443434585167,0.00331797919359127,0.0385411042390779,0.0515475826779556,1.07527573392063e-41
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23474.3-Hydroxybutyrate,41908,0.00484892732122873,0.00351056149764911,-0.00203177321416353,0.011729627856621,0.16722951021384
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23475.Acetate,42115,-0.00752456811502217,0.00329426381451901,-0.0139813251914794,-0.0010678110385649,0.0223793000048421
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23476.Acetoacetate,42124,-0.0137028826271304,0.0033731607744761,-0.0203142777451035,-0.0070914875091572,4.88727347191515e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23477.Acetone,42124,-0.0151612020246206,0.00334662490253983,-0.0217205868335987,-0.00860181721564257,5.94284905869591e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23478.Creatinine,41831,0.159899182599097,0.00348531711719494,0.153067961049395,0.166730404148799,0
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23479.Albumin,42122,-0.0593731419847185,0.00329870388342774,-0.0658386015962368,-0.0529076823732001,1.48027872564973e-71
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23480.Glycoprotein Acetyls,42125,0.0427521451253254,0.00352114308711029,0.0358507046745893,0.0496535855760616,9.7063104532121e-34
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42125,0.0187389920734794,0.0035653161215239,0.0117509724752926,0.0257270116716663,1.49635164578222e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42125,0.0164499812112983,0.00352395407666834,0.00954303122102833,0.0233569312015682,3.07132506006356e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42125,0.0193687279048553,0.00357448125140849,0.0123627446520946,0.0263747111576159,6.11397263577548e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42125,0.0160308327593823,0.00353933842371857,0.00909372944889388,0.0229679360698707,5.97003159018428e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42125,0.0148814963007504,0.00349728790990354,0.00802681199733947,0.0217361806041613,2.10377202573969e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42125,0.0171770145181676,0.00357066957509017,0.0101785021509909,0.0241755268853443,1.52186294955572e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42125,0.0154146819881806,0.00348860918247692,0.00857700799052579,0.0222523559858353,1.00162029677266e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42125,0.0118406061958253,0.00355059534678701,0.00488143931612272,0.0187997730755278,0.000855938448992227
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42125,0.0100475316748727,0.00353396699896589,0.00312095635689958,0.0169741069928459,0.00447426951997763
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42125,0.0122516731832752,0.00352207844966602,0.00534839942192981,0.0191549469446206,0.000505821586855222
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42125,0.0059596679161382,0.00344182395368595,-0.000786307033086265,0.0127056428653627,0.0833787224091395
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42125,0.0013526620202521,0.00338774884859208,-0.00528732572298838,0.00799264976349257,0.689693135044506
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42125,0.0107720000345035,0.00349526283851191,0.00392128487102017,0.0176227151979868,0.00206126376428231
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42125,0.0105714536432565,0.00355350083514347,0.00360659200637535,0.0175363152801377,0.00293586825483572
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42125,0.00863110894881926,0.00350649706194636,0.00175837470740438,0.0155038431902341,0.0138501687700383
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,42125,0.00546605558326895,0.0034862913595576,-0.00136707548146394,0.0122991866480018,0.116935678572857
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,42125,0.0118108665183379,0.0035051260837359,0.0049408193942155,0.0186809136424602,0.000754979026197872
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,42125,0.00620060520874424,0.00343532211954337,-0.000532626145560761,0.0129338365630492,0.0711048231436505
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42125,0.00463441011742943,0.00337504248085594,-0.00198067314504822,0.0112494933799071,0.16973224250619
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42125,0.00735939391677906,0.00349829353788834,0.000502738582517911,0.0142160492510402,0.0354230430778171
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,42125,0.00179618586746466,0.00348125220160966,-0.00502706844769026,0.00861944018261959,0.605891372888072
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42125,-0.0134970136518348,0.00328642477193573,-0.0199384062048288,-0.00705562109884074,4.0347431634921e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42125,-0.0104363331485161,0.003321260807465,-0.0169460043311475,-0.00392666196588474,0.00168015835205882
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42125,-0.0135110819722322,0.00327231396743624,-0.0199248173484072,-0.00709734659605714,3.66779595951384e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42125,-0.0243457876339291,0.00321110128560907,-0.0306395461537229,-0.0180520291141353,3.64128925194929e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42125,-0.0286455690555804,0.00321916820816235,-0.0349551387435786,-0.0223359993675822,6.40997384603098e-19
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42125,-0.0172606143553407,0.00324818515850896,-0.0236270572660183,-0.0108941714446632,1.09070003909758e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42125,0.000723265565787025,0.00344971795005218,-0.00603818161631524,0.00748471274788929,0.833936870195982
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42125,0.00810214990084107,0.00339432107174507,0.00144928060022074,0.0147550192014614,0.0170020617453179
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,42125,0.00329260576010127,0.00338460951413918,-0.00334122888761153,0.00992644040781406,0.330662446149042
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,42125,-0.00863613210898371,0.00330432820259656,-0.015112615386073,-0.00215964883189446,0.00897024060452629
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,42125,-0.00754352806453371,0.00327467883789212,-0.0139618985868023,-0.00112515754226515,0.021261270294078
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42125,-0.0019706903928871,0.00329230848830738,-0.00842361502996956,0.00448223424419537,0.549467456299507
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42125,-0.0168326277153552,0.00324671664930676,-0.0231961923479965,-0.010469063082714,2.19853276533432e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,42125,0.018854192562347,0.00351119555231853,0.0119722492798027,0.0257361358448913,8.02159223675815e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42125,-0.00158854912021697,0.00330655234943267,-0.008069391725105,0.00489229348467106,0.63093362621974
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42125,-0.000200378551325365,0.0033373100337755,-0.00674150621752535,0.00634074911487462,0.95212316365903
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42125,0.00754466177971947,0.00333966321264957,0.00099892188292631,0.0140904016765126,0.0238932123242691
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42125,-0.015855713598855,0.00329098803394648,-0.0223060501453901,-0.00940537705231988,1.46709886719354e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42125,-0.021274976057883,0.00329220157317947,-0.0277276911413148,-0.0148222609744513,1.06869028210767e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42125,-0.00284129585044773,0.00331210684575158,-0.00933302526812083,0.00365043356722537,0.390990363247158
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42125,0.0274351676403389,0.00350577883901595,0.0205638411158676,0.0343064941648102,5.43963507983273e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23523.Concentration of IDL Particles,42125,-0.0303014394679491,0.00319340132442123,-0.0365605060638147,-0.0240423728720834,2.74199120706428e-21
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23524.Total Lipids in IDL,42125,-0.040146543406883,0.0032780585263806,-0.046571538118589,-0.0337215486951771,2.69799958586414e-34
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23525.Phospholipids in IDL,42125,-0.0341728205074414,0.00329171302715412,-0.0406245780406634,-0.0277210629742193,3.78005049374647e-25
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23526.Cholesterol in IDL,42125,-0.0459318898534495,0.00327029146851312,-0.0523416611317352,-0.0395221185751638,1.74929583851682e-44
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42125,-0.0470236979676743,0.00327113648256368,-0.0534351254734992,-0.0406122704618495,1.68618531661059e-46
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23528.Free Cholesterol in IDL,42125,-0.0417883799898137,0.00326717014627772,-0.048192033476518,-0.0353847265031093,3.11886329410983e-37
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23529.Triglycerides in IDL,42125,0.0206059962366426,0.00351166277235626,0.0137231372028243,0.0274888552704609,4.52227290706504e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,42125,-0.0248292733166578,0.00321686341426049,-0.0311343256086084,-0.0185242210247073,1.26355088203086e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23531.Total Lipids in Large LDL,42125,-0.0434614710709231,0.00324448384282109,-0.0498206594028524,-0.0371022827389938,1.19867270351686e-40
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23532.Phospholipids in Large LDL,42125,-0.0451385140834795,0.0032188721134293,-0.051447503425801,-0.0388295247411581,2.37842553069895e-44
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23533.Cholesterol in Large LDL,42125,-0.0458360808256869,0.00324824099698199,-0.0522026331797716,-0.0394695284716022,6.98802685905557e-45
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42125,-0.0446017678255263,0.00324939029448612,-0.0509705728027191,-0.0382329628483335,1.40624280143479e-42
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42125,-0.0481100307907351,0.00325199632695045,-0.054483943591558,-0.0417361179899122,4.03526456678374e-49
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23536.Triglycerides in Large LDL,42125,0.0124138469266794,0.00351259310313968,0.00552916444452564,0.0192985294088332,0.000410598437184134
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42125,-0.0292052194091453,0.00323359852070883,-0.0355430725097346,-0.022867366308556,1.92550589959628e-19
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,42125,-0.0364903202786262,0.00324329591846948,-0.0428471802788264,-0.0301334602784261,3.1302588633609e-29
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,42125,-0.0373184651987225,0.00323548045888114,-0.0436600068981296,-0.0309769234993155,1.2534400132549e-30
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,42125,-0.0389122701986823,0.00323399511621627,-0.0452509006264661,-0.0325736397708984,3.61563422593978e-33
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42125,-0.0356821012863837,0.0032535098156691,-0.0420589805250951,-0.0293052220476722,7.28401649164155e-28
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42125,-0.0456343561193145,0.00321791762224725,-0.0519414746589191,-0.0393272375797099,2.61234400182762e-45
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,42125,0.0131856884655112,0.00352656884850756,0.00627361352243642,0.020097763408586,0.000185582502591503
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,42125,-0.0184867347845434,0.00322248813813592,-0.0248028115352898,-0.012170658033797,9.8650365203799e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23545.Total Lipids in Small LDL,42125,-0.0304152113760021,0.00321740862491372,-0.036721332280833,-0.0241090904711713,3.84076359688645e-21
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23546.Phospholipids in Small LDL,42125,-0.0280093257181555,0.00319523031879488,-0.0342719771429934,-0.0217466742933175,2.0806824757977e-18
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23547.Cholesterol in Small LDL,42125,-0.0345539424478124,0.00321301578238758,-0.040851453381292,-0.0282564315143327,7.34165542979832e-27
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42125,-0.030930627669204,0.00323469213346633,-0.0372706242507981,-0.02459063108761,1.35934917312456e-21
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42125,-0.0406192791548687,0.00319989880720268,-0.0468910808169859,-0.0343474774927514,1.05779179538301e-36
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23550.Triglycerides in Small LDL,42125,0.0165875651678163,0.00354498129599107,0.00963940182767378,0.0235357285079588,2.90961347433079e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42125,-0.0109366646693677,0.00368694943230973,-0.0181630855566948,-0.00371024378204065,0.00301939651957888
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42125,-0.0098814589935351,0.00370640132719425,-0.0171460055948358,-0.00261691239223436,0.00768432328285773
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42125,-0.00533242898499968,0.00373005418080218,-0.012643335179372,0.0019784772093726,0.152860361660888
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42125,-0.0181459416478955,0.00366566247206828,-0.0253306400931493,-0.0109612432026417,7.50529534550003e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42125,-0.0231957121834889,0.00370175561302356,-0.0304511531850151,-0.0159402711819628,3.81859008020747e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42125,-0.000890205060839981,0.00351145024326161,-0.00777264753763274,0.00599223741595278,0.799874356187637
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42125,0.0269993824613999,0.0034484808369118,0.0202403600210528,0.0337584049017471,5.28445479867671e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,42125,-0.039875358406391,0.00384008112489786,-0.0474019174111908,-0.0323487994015912,3.68241734611835e-25
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23559.Total Lipids in Large HDL,42125,-0.0404311331378143,0.00384536414204216,-0.0479680468562169,-0.0328942194194116,9.43337858073731e-26
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23560.Phospholipids in Large HDL,42125,-0.0405314374442994,0.00384201089601302,-0.048061778800485,-0.0330010960881139,6.50482658046046e-26
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23561.Cholesterol in Large HDL,42125,-0.0425021227282609,0.00380434857957135,-0.0499586459442208,-0.0350455995123011,7.57865256651423e-29
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42125,-0.0434991586248072,0.00379704508432195,-0.0509413669900782,-0.0360569502595361,3.0677955150384e-30
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42125,-0.037324704935054,0.00381313044718335,-0.0447984406115334,-0.0298509692585747,1.51124655562154e-22
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23564.Triglycerides in Large HDL,42125,0.0224555390784232,0.00356213275980343,0.0154737588692085,0.0294373192876379,2.99568168429896e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42125,-0.061794848591613,0.00356221310967768,-0.0687767862865813,-0.0548129108966448,1.17226215539128e-66
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,42125,-0.0598515741624906,0.00353516740344561,-0.0667805022732439,-0.0529226460517372,1.30036615661451e-63
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,42125,-0.0561454719074364,0.00352124659398974,-0.0630471152316563,-0.0492438285832165,1.07388634174616e-56
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,42125,-0.0677446519999093,0.0035463951865738,-0.0746955865655939,-0.0607937174342246,3.06009799709161e-80
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42125,-0.0680583496686813,0.00352805983977086,-0.0749733469546322,-0.0611433523827304,9.03986374426717e-82
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42125,-0.063623562624745,0.00361235864867461,-0.0707037855761473,-0.0565433396733428,1.2420660008031e-68
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,42125,0.0135443675062275,0.00346034098606898,0.00676209917353228,0.0203266358389227,9.11803086003128e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,42125,-0.0661889749909166,0.0032548951682437,-0.0725685695206743,-0.0598093804611589,1.62356082302675e-90
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23573.Total Lipids in Small HDL,42125,-0.0577615039313513,0.00329313311331162,-0.064216044833442,-0.0513069630292605,4.34866585881189e-68
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23574.Phospholipids in Small HDL,42125,-0.0554601349929909,0.00331744324357957,-0.0619623237504069,-0.0489579462355749,4.36032884054559e-62
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23575.Cholesterol in Small HDL,42125,-0.0697641830948375,0.00324723835024889,-0.0761287702613253,-0.0633995959283496,1.2456647149751e-100
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42125,-0.0709959434885162,0.00322734344639886,-0.0773215366434579,-0.0646703503335744,2.52661945323036e-105
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42125,-0.0557761814569207,0.00335092454177275,-0.0623439935587953,-0.0492083693550461,1.43582838006454e-61
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23578.Triglycerides in Small HDL,42125,0.0199973145271795,0.00352096454844546,0.0130962240122264,0.0268984050421326,1.37999956051125e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41650,0.0205387636315,0.00339326479232103,0.0138879646385508,0.0271895626244492,1.46438450650026e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41650,-0.00724690204947916,0.00349287390936049,-0.0140929349118257,-0.000400869187132605,0.0380285509313353
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41650,-0.00760652129809659,0.00345317684097687,-0.0143747479064113,-0.000838294689781917,0.0276298855498065
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41650,-0.00544858379244053,0.00351329408662896,-0.0123346402022333,0.00143747261735224,0.120963609905283
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41650,0.000919675899757085,0.00346800586296774,-0.00587761559165969,0.00771696739117386,0.790868502569497
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42012,0.0171936217957599,0.00336416772707172,0.0105998530506994,0.0237873905408205,3.25398084219945e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42012,-0.0163116837671385,0.00352940686627476,-0.023229321225037,-0.00939404630923996,3.84413026264538e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42012,-0.0205106778358111,0.00353047986950402,-0.027430418380039,-0.0135909372915832,6.41097166301808e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42012,0.00113882279667192,0.00348886930106274,-0.00569936103341106,0.0079770066267549,0.744114955255435
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42012,0.00982504876968496,0.00346391418716156,0.00303577696284831,0.0166143205765216,0.00456966772553343
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42124,0.0398066289016512,0.00343579513401968,0.0330724704389726,0.0465407873643297,6.90568965022717e-31
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42124,-0.000285502217455101,0.00334887475845168,-0.00684929674402039,0.00627829230911019,0.932061434062638
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42124,-0.00362542455877433,0.00344733310929153,-0.0103821974529857,0.00313134833543707,0.292974927043987
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42124,0.0102901722744042,0.00330048038725378,0.00382123071538678,0.0167591138334216,0.00182618445970874
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42124,-0.0151834000025702,0.00328844932739486,-0.0216287606842641,-0.00873803932087629,3.92715563174972e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42125,-0.0193629251068042,0.00334542123628821,-0.0259199507299291,-0.0128058994836793,7.29304707172918e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42125,-0.0292749592686411,0.00346770709452262,-0.0360716651739055,-0.0224782533633768,3.44469832849623e-17
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42125,-0.0307955415624559,0.00350346412093098,-0.0376623312394806,-0.0239287518854312,1.68238731085695e-18
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42125,-0.0243102252553683,0.00338545319087601,-0.0309457135094853,-0.0176747370012513,7.31003508021236e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42125,0.0271169082146045,0.00343748801802648,0.0203794316992726,0.0338543847299364,3.30106148143934e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42125,-0.0457118232662972,0.00344496444020106,-0.0524639535690913,-0.0389596929635031,6.37144356000579e-40
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42125,-0.0284670658976446,0.00337020155017645,-0.0350726609359904,-0.0218614708592988,3.31440941648972e-17
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42125,-0.0137107140105539,0.00330965436798224,-0.0201976365717991,-0.00722379144930873,3.45510570703975e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42125,-0.0453090594080005,0.00345889794066214,-0.0520884993716982,-0.0385296194443027,5.88281609867631e-39
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42125,0.0341495542742406,0.00339661696170834,0.0274921850292922,0.0408069235191889,1.0779601167706e-23
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42125,0.0654555294641788,0.00333193863033579,0.0589249297487207,0.071986129179637,1.09243500972049e-84
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42125,-0.0480619465202734,0.00348201147384373,-0.0548866890090071,-0.0412372040315397,4.93901626305612e-43
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42125,-0.0510306107223949,0.00350728664717245,-0.0579048925508529,-0.044156328893937,1.389744944095e-47
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42125,-0.0190411758006651,0.00332184738704917,-0.0255519966792815,-0.0125303549220488,1.01407766788711e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42125,0.0395552469296789,0.00347657409833235,0.0327411616969475,0.0463693321624103,7.49213622007646e-30
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42125,0.052276666027872,0.00315733085347724,0.0460882975550566,0.0584650345006874,6.01162324944176e-61
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42125,-0.0630034344463112,0.00333431773097804,-0.0695386971990282,-0.0564681716935943,1.4173993224112e-78
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42125,-0.0645321914560058,0.00332506605163746,-0.0710493209172152,-0.0580150619947964,9.91831001449145e-83
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42125,-0.0253905517161041,0.00324252338284756,-0.0317458975464853,-0.0190352058857229,5.23714718793121e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42125,0.0600358845224941,0.00345155752443368,0.0532708317746041,0.0668009372703842,5.30703963567653e-67
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42125,-0.00678401937657501,0.00324071179064563,-0.0131358144862404,-0.000432224266909584,0.0363352792922798
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42125,-0.0620555764885645,0.00346899696557245,-0.0688548105410865,-0.0552563424360425,1.02675665875304e-70
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42125,-0.0383905246216623,0.00325252202816958,-0.0447654677968746,-0.0320155814464499,5.47590343526002e-32
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42125,-0.0426109352920101,0.00348566404955607,-0.04944283682914,-0.0357790337548802,3.54499481204266e-34
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42125,0.0631633638891509,0.00345987038223114,0.0563820179399779,0.0699447098383239,1.55088354659933e-73
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42125,0.00187271908177878,0.00331012952761844,-0.00461513479235335,0.00836057295591092,0.571570825002018
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42125,-0.0520793261794553,0.00320042590939791,-0.0583521609618752,-0.0458064913970354,5.94098238453187e-59
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42125,-0.01506261023287,0.0033343088256348,-0.0215978555311142,-0.00852736493462577,6.31398487615893e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42125,-0.0378688659596063,0.00356333677747463,-0.0448530060434566,-0.030884725875756,2.8531847931615e-26
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42125,0.060523734480316,0.00340277250685891,0.0538543003668725,0.0671931685937594,6.09933207336862e-70
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42125,0.0191946845274383,0.00326953164722365,0.0127864024988799,0.0256029665559966,4.44405941368205e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42125,-0.051975572691293,0.00326592562885567,-0.0583767869238501,-0.0455743584587359,1.72645142334653e-56
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42125,-0.0186605194360695,0.00327070628213928,-0.0250711037490625,-0.0122499351230765,1.18651338302337e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42125,-0.0417507736961936,0.0034912124795782,-0.0485935501561669,-0.0349079972362203,8.69305699570505e-33
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42125,0.0488065227140923,0.00348665699299738,0.0419726750078175,0.0556403704203672,3.36418262624959e-44
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42117,0.0108865656369442,0.00364595657026654,0.00374049075922174,0.0180326405146666,0.00283248525410534
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42117,-0.0327426395323648,0.00343385337102408,-0.039472992139572,-0.0260122869251576,1.75942142024207e-21
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42117,-0.0591544973594207,0.00330775722834632,-0.0656377015269795,-0.0526712931918619,1.12312111888169e-70
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42117,0.0235453676478196,0.00381409374995812,0.0160697438979016,0.0310209913977375,6.8901481703185e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42117,0.0291310962555038,0.00363268923006151,0.0220110253645832,0.0362511671464244,1.15597619258678e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42125,0.00797674526288296,0.00354527025691321,0.00102801555933306,0.0149254749664329,0.0244677082858968
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42125,-0.0352218528174169,0.00365696501801077,-0.042389504252718,-0.0280542013821158,6.97494071820108e-22
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42125,-0.0381496738218911,0.00368144055366439,-0.0453652973070733,-0.0309340503367089,4.59308319475298e-25
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42125,-0.0136330347692898,0.00347433402098962,-0.0204427294504294,-0.00682334008815009,8.75678493743727e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42125,0.0539635405349588,0.00359584523097823,0.0469156838822414,0.0610113971876761,1.75179167751883e-50
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42125,0.0479286207577119,0.0035825719257531,0.0409067797832358,0.054950461732188,1.50666743951216e-40
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42125,-0.0543530551654178,0.00354635601123519,-0.0613039129474388,-0.0474021973833968,1.47372170705999e-52
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42125,-0.0480170476134023,0.00353063696364554,-0.0549370960621476,-0.0410969991646571,7.75353892152922e-42
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42125,-0.0575296751358855,0.00370166581977402,-0.0647849401426426,-0.0502744101291284,5.58124021848042e-54
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42125,0.0539222056954683,0.00349788621879346,0.0470663487066331,0.0607780626843035,3.81214051280072e-53
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42125,0.0117098608318893,0.00345376968497891,0.00494047224933064,0.018479249414448,0.000699846499583612
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42125,-0.045300106216868,0.00343055147938989,-0.0520239871164722,-0.0385762253172638,1.48186305014494e-39
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42125,-0.0472139532778801,0.00345874903153489,-0.0539931013796885,-0.0404348051760717,3.92158405314392e-42
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42125,-2.84657928852332e-05,0.00344161650485942,-0.00677403414240969,0.00671710255663922,0.99340085725837
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42125,0.0558228218934525,0.0035295476878216,0.0489049084253222,0.0627407353615829,8.06247636509069e-56
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51242,-0.00351556225418121,0.00279138725354893,-0.00898668127113711,0.0019555567627747,0.207887692443731
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51242,-0.00180550800698136,0.00271930538945001,-0.00713534657030337,0.00352433055634066,0.506723326094795
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49827,9.65861594621172e-05,0.00259737778842712,-0.00499427430585504,0.00518744662477927,0.970337039831052
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49827,-0.00160023874740395,0.00285621199149715,-0.00719841425073836,0.00399793675593047,0.57530403091491
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49827,-0.00320445956567894,0.00278443811279651,-0.00866195826676009,0.00225303913540222,0.24980891833924
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49827,-0.000582038098927011,0.00254112782842036,-0.00556264864263092,0.0043985724447769,0.818834536134596
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24009.Traffic intensity on the nearest road,51242,-0.0594523779137408,0.0776157368702008,-0.211579222179334,0.0926744663518528,0.443694288856769
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24010.Inverse distance to the nearest road,51242,0.00080410079898184,0.00244019094912988,-0.00397867346131272,0.0055868750592764,0.741762998520709
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24011.Traffic intensity on the nearest major road,51242,0.0019035477022121,0.00240802816003795,-0.00281618749146229,0.00662328289588648,0.429243975079312
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24012.Inverse distance to the nearest major road,51242,-0.00282882060842218,0.00245581109491224,-0.00764221035445017,0.0019845691376058,0.249379376101001
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24013.Total traffic load on major roads,51242,-0.00965091190187828,0.0537167059543786,-0.11493565557246,0.0956338317687037,0.857418685970692
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24015.Sum of road length of major roads within 100m,51242,-0.0365990767498724,0.0528408212351362,-0.140167086370739,0.0669689328709946,0.488549801485317
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51242,-0.00502503011841213,0.00277010690626944,-0.0104544396547002,0.000404379417875971,0.0696881897970944
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51242,-0.00589819738262668,0.00276326582629835,-0.0113141984021714,-0.0004821963630819,0.0328126783801995
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51242,-0.0049798167192984,0.00273329406863258,-0.0103370730938183,0.000377439655221444,0.0684821331094254
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51189,-0.00290934334813312,0.00273286947759722,-0.00826576752422366,0.00244708082795743,0.287080179374304
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24020.Average daytime sound level of noise pollution,51242,-0.00227226527693089,0.00245520405460467,-0.00708446522395604,0.00253993467009426,0.354721535101534
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24021.Average evening sound level of noise pollution,51242,-0.00224266885121361,0.00245573607800181,-0.00705591156409717,0.00257057386166994,0.361127936410649
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24022.Average night-time sound level of noise pollution,51242,-0.00226617097743847,0.00245522822739177,-0.00707841830312633,0.00254607634824939,0.35601829819007
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51242,-0.00221940689547932,0.00245540571973294,-0.00703200210615588,0.00259318831519723,0.366065720225109
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51242,-0.0022197062084539,0.00245531685015858,-0.00703212723476473,0.00259271481785692,0.365983731511721
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2405.Number of children fathered,39701,-0.187191392713448,0.0590030728838284,-0.302837415565752,-0.0715453698611443,0.00151531017313048
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49016,0.00556186406128864,0.00284065539009905,-5.82050330549116e-06,0.0111295486258828,0.0502497702044108
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49016,0.00310485833746245,0.0025548342989217,-0.00190261688842408,0.00811233356334898,0.224270910099111
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24502.Water percentage, buffer 1000m",49016,-0.00413282146760739,0.00259684482942735,-0.009222637333285,0.000956994398070222,0.111517984408037
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49016,0.00402159324392463,0.00266325554749389,-0.00119838762916339,0.00924157411701264,0.131051951349715
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49016,0.00308396837031225,0.00256718002131754,-0.00194770447147013,0.00811564121209462,0.229646936529513
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24505.Water percentage, buffer 300m",49016,-0.00404552722898271,0.00261829290137978,-0.00917738131568709,0.00108632685772166,0.12233777613169
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51376,0.00434949172762797,0.00272652884671569,-0.000994504811934781,0.00969348826719072,0.110670867924021
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51376,0.000631205420751228,0.00255293013567907,-0.00437253764517974,0.0056349484866822,0.804719027151024
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24508.Distance (Euclidean) to coast,51376,0.00681940349081559,0.00241119937136154,0.00209345272294697,0.0115453542586842,0.00468495060162764
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35332,0.0563727921783391,0.0740821682333241,-0.0888282575589762,0.201573841915654,0.446716435873142
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2704.Years since last cervical smear test,38161,-0.0586947193265559,0.0637233290660142,-0.183592444295944,0.066203005642832,0.357029873667085
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2714.Age when periods started (menarche),40486,0.0850642660746276,0.0507763161210782,-0.0144573135226857,0.184585845671941,0.0939080800430538
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2734.Number of live births,40824,-0.0344043234022057,0.0493311069503803,-0.131093293024951,0.0622846462205397,0.485556185765981
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2744.Birth weight of first child,39047,-0.164889495405597,0.0526122886202104,-0.26800958110121,-0.0617694097099847,0.00172918497187653
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2754.Age at first live birth,37864,-0.0167983679125376,0.00422502131717928,-0.025079409694209,-0.00851732613086625,7.06755271376738e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2764.Age at last live birth,37837,-0.0118973295984722,0.00389142011280758,-0.019524513019575,-0.00427014617736932,0.00224005512157384
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2794.Age started oral contraceptive pill,36804,0.00332930072048123,0.0059797932693791,-0.0083910940875018,0.0150496955284643,0.577708812851114
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2804.Age when last used oral contraceptive pill,36048,-0.00121325998198861,0.00449400712229572,-0.0100215139416882,0.007594993977711,0.787189255299855
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2867.Age started smoking in former smokers,35975,-0.0229744512204618,0.00472548774799213,-0.0322364072065264,-0.0137124952343972,1.18932002189673e-06
EPHA2,Ephrin type-A receptor 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35821,0.0186995085992833,0.0924604162232372,-0.162522907198262,0.199921924396828,0.83973265863942
EPHA2,Ephrin type-A receptor 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35817,0.0650250469377676,0.100803213485621,-0.132549251494049,0.262599345369584,0.518904701727319
EPHA2,Ephrin type-A receptor 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35833,0.138486205177901,0.104821282102579,-0.0669635077431548,0.343935918098956,0.186491911372188
EPHA2,Ephrin type-A receptor 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35807,0.234596835624647,0.10241337855367,0.0338666136594544,0.43532705758984,0.022012941244507
EPHA2,Ephrin type-A receptor 2,Mental health,X28739.Difficulty with standing for long periods,35841,0.585696890971234,0.0789033450860118,0.431046334602651,0.740347447339817,1.28831958380242e-13
EPHA2,Ephrin type-A receptor 2,Mental health,X28740.Difficulty with taking care of household responsibilities,35862,0.359206549100652,0.0874681062132774,0.187769060922628,0.530644037278676,4.06126570885971e-05
EPHA2,Ephrin type-A receptor 2,Mental health,X28741.Difficulty learning a new task,35803,0.155321731477927,0.100078187097631,-0.0408315152334305,0.351474978189284,0.120709206466951
EPHA2,Ephrin type-A receptor 2,Mental health,X28742.Difficulty with joining in community activities,35542,0.203485193680245,0.107557352132588,-0.00732721649962709,0.414297603860117,0.058552970666012
EPHA2,Ephrin type-A receptor 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,35820,0.35188934078181,0.0896234821139322,0.176227315838503,0.527551365725118,8.71350775940073e-05
EPHA2,Ephrin type-A receptor 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35864,0.219933497119174,0.13692908268138,-0.0484475049363308,0.488314499174679,0.108280532672731
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,35523,0.108061567785691,0.0686921387712687,-0.0265750242059953,0.242698159777378,0.115739029711033
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2897.Age stopped smoking,35975,0.0225160237563288,0.0044865016495741,0.0137224805231636,0.0313095669894941,5.33710120332885e-07
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35159,-0.0109078965052605,0.00919186799352411,-0.0289239577725678,0.00710816476204676,0.235397237555041
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35159,0.00846184442339719,0.0103213439744886,-0.0117679897666005,0.0286916786133948,0.41234042525079
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35159,0.0481470797788477,0.0334848629946451,-0.0174832516906566,0.113777411248352,0.150521707215279
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35159,0.0309413483108403,0.0390343670973816,-0.0455660112000275,0.107448707821708,0.428001988076285
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35159,0.104045382054028,0.0484087756686258,0.00916418174352157,0.198926582364535,0.0316500776839684
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35159,-0.0115769325423801,0.040595810083046,-0.0911447203051503,0.0679908552203902,0.775519550597248
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35159,-0.003494500290723,0.016803945384702,-0.0364302332447389,0.0294412326632929,0.835269538702296
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35159,0.0148104650098254,0.0287885306249649,-0.0416150550151058,0.0712359850347566,0.606951481029395
EPHA2,Ephrin type-A receptor 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,35115,0.0791616217675768,0.106914675312635,-0.130391141845187,0.288714385380341,0.459075361879101
EPHA2,Ephrin type-A receptor 2,Mental health,X29003.Recent feelings of depression,35104,0.105068349146545,0.103782066779609,-0.0983445017414889,0.308481200034578,0.311391130897333
EPHA2,Ephrin type-A receptor 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35117,-0.00808557573814321,0.0821358585811501,-0.169071858557197,0.152900707080911,0.921585068093349
EPHA2,Ephrin type-A receptor 2,Mental health,X29005.Recent feelings of tiredness or low energy,35120,0.155631102465621,0.0807771540783834,-0.00269211952801038,0.313954324459253,0.054068265896441
EPHA2,Ephrin type-A receptor 2,Mental health,X29006.Recent poor appetite or overeating,35130,0.186774098471736,0.12373557290309,-0.05574762441832,0.429295821361792,0.131234097137649
EPHA2,Ephrin type-A receptor 2,Mental health,X29007.Recent feelings of inadequacy,35096,0.260908682043965,0.115866522117759,0.0338102986931571,0.488007065394773,0.0243712974556919
EPHA2,Ephrin type-A receptor 2,Mental health,X29008.Recent trouble concentrating on things,35131,0.0281223529584091,0.113110678068794,-0.193574576056428,0.249819281973246,0.803658030360447
EPHA2,Ephrin type-A receptor 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35123,0.410884795631402,0.18441183098644,0.0494376068979795,0.772331984364825,0.0259123851737755
EPHA2,Ephrin type-A receptor 2,Mental health,X29010.Recent thoughts of suicide or self-harm,35101,0.598693710258358,0.204962214548953,0.19696776974241,1.00041965077431,0.0035023631880187
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#0.Substances taken for depression_None of options listed,36110,-0.0402826074869107,0.0207588185094247,-0.0809698917653831,0.000404676791561753,0.0523588390126362
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),36110,-0.106827477664925,0.0554219215711942,-0.215454443944466,0.00179948861461569,0.0539543808623083
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),36110,-0.0444454176170302,0.0211872286116188,-0.085972385695803,-0.00291844953825746,0.0359638149270532
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),36110,0.108974283929553,0.0641108933474859,-0.0166830670315193,0.234631634890625,0.0892176639282302
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),36110,-0.0349575716205088,0.0541614888988062,-0.141114089862169,0.0711989466211514,0.518668521503932
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),36110,-0.0184556877226239,0.0553610955918548,-0.126963435082659,0.0900520596374116,0.738865666771574
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),36110,-0.0693652780194487,0.0581095364472151,-0.18325996945599,0.0445294134170928,0.232636793165393
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),36110,0.0847078946226978,0.0581381240628373,-0.0292428285404633,0.198658617785859,0.145158703785086
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),36110,-0.00989178672174049,0.0376400319937799,-0.0836662494295491,0.0638826759860682,0.79271284375805
EPHA2,Ephrin type-A receptor 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,36110,-0.0651271004734301,0.0189588620738556,-0.102286470138187,-0.0279677308086731,0.000595640576525386
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,36110,-0.0346309078928967,0.0331167881686163,-0.0995398127033847,0.0302779969175913,0.295726591417212
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,36110,-0.0810751286212838,0.0519339619920461,-0.182865694125694,0.0207154368831265,0.118541276856408
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,36110,-0.0382724704665942,0.0739375250819341,-0.183190019627185,0.106645078693997,0.604731215059245
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,36110,0.0219189734432463,0.0503758432419951,-0.076817679311064,0.120655626197557,0.663497022459305
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,36110,-0.0492703989075948,0.0710838511452575,-0.1885947471523,0.0900539493371099,0.488250813509677
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,36110,-0.0799878812903643,0.0711180874106495,-0.219379332615237,0.0594035700345086,0.260747058427298
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,36110,0.0102395829805143,0.0407538811928613,-0.0696380241574937,0.0901171901185224,0.801625063097413
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,36110,0.0248310637335805,0.038635587039236,-0.050894686863322,0.100556814330483,0.520440557620939
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,36110,-0.01392437801338,0.0541036309629786,-0.119967494700818,0.0921187386740581,0.796904717986459
EPHA2,Ephrin type-A receptor 2,Mental health,X29058.Recent feelings or nervousness or anxiety,35027,0.00416260446214342,0.096311412172766,-0.184607763396478,0.192932972320765,0.965527433342438
EPHA2,Ephrin type-A receptor 2,Mental health,X29059.Recent inability to stop or control worrying,35041,0.0269378247014772,0.0976599528027914,-0.164475682791994,0.218351332194948,0.782686190124666
EPHA2,Ephrin type-A receptor 2,Mental health,X29060.Recent worrying too much about different things,35037,-0.0170113109369719,0.0911539313350691,-0.195673016353707,0.161650394479764,0.851963652565198
EPHA2,Ephrin type-A receptor 2,Mental health,X29061.Recent trouble relaxing,35035,0.145186815186546,0.0977497221568989,-0.046402640240976,0.336776270614068,0.137520650856412
EPHA2,Ephrin type-A receptor 2,Mental health,X29062.Recent restlessness,35051,0.279972374622672,0.141053921766066,0.00350668796118375,0.556438061284161,0.0472065742324345
EPHA2,Ephrin type-A receptor 2,Mental health,X29063.Recent easy annoyance or irritability,35021,0.126744679536684,0.0996471545866735,-0.0685637434531962,0.322053102526564,0.203447077270435
EPHA2,Ephrin type-A receptor 2,Mental health,X29064.Recent feelings of foreboding,35024,0.18266988318498,0.11226885844574,-0.0373770793686691,0.40271684573863,0.103775171824973
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,36110,-0.0373914185648242,0.0237334338116216,-0.0839089488356026,0.00912611170595419,0.115192710465602
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,36110,-0.0346755725210188,0.0417805369022781,-0.116565424849484,0.0472142798074463,0.406598191158195
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',36110,-0.00398746467209497,0.0519282293671705,-0.105766794231749,0.0977918648875593,0.938794421476014
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,36110,0.0397790828862727,0.04854943661839,-0.0553778128857716,0.134935978658317,0.412613788596095
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,36110,0.00837392978692462,0.0374760114452063,-0.0650790526456797,0.081826912219529,0.823193657471649
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,36110,0.00766779863323087,0.0386879149645446,-0.0681605146972765,0.0834961119637383,0.842897367515397
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,36110,-0.0364708599994196,0.0390933165262544,-0.113093760390878,0.0401520403920391,0.350894857637752
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,36110,-0.0188121305920531,0.0391183727856744,-0.0954841412519749,0.0578598800678686,0.630600875513169
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,36110,-0.0438201073008928,0.0509274533257157,-0.143637915819295,0.0559977012175098,0.389575404113575
EPHA2,Ephrin type-A receptor 2,Mental health,X29076.Felt loved as a child,35020,-0.132162806369973,0.083466394961109,-0.295756940493746,0.0314313277538011,0.113378852628999
EPHA2,Ephrin type-A receptor 2,Mental health,X29077.Physically abused by family as a child,35041,0.0562525441993669,0.124806327750753,-0.188367858192109,0.300872946590843,0.652209033486573
EPHA2,Ephrin type-A receptor 2,Mental health,X29078.Felt hated by family member as a child,35027,0.158597171666501,0.122690174179362,-0.081875569725049,0.399069913058051,0.196178519999854
EPHA2,Ephrin type-A receptor 2,Mental health,X29079.Sexually molested as a child,34990,-0.133279464445176,0.160476663509188,-0.447813724923184,0.181254796032833,0.406277712055016
EPHA2,Ephrin type-A receptor 2,Mental health,X29080.Someone to take to doctor when needed as a child,34999,0.0551472586658654,0.11642892395075,-0.173053432277605,0.283347949609336,0.635763054490697
EPHA2,Ephrin type-A receptor 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35031,0.0139099892035018,0.183600543698616,-0.345947076445785,0.373767054852788,0.939610851476361
EPHA2,Ephrin type-A receptor 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34989,0.00514846923133373,0.137511741196063,-0.264374543512949,0.274671481975617,0.97013529759748
EPHA2,Ephrin type-A receptor 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35037,0.0464463398860996,0.160045529533491,-0.267242897999543,0.360135577771742,0.771668148563711
EPHA2,Ephrin type-A receptor 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35027,0.186982860123089,0.217272862502,-0.238871950380831,0.612837670627009,0.389499253886826
EPHA2,Ephrin type-A receptor 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35025,-0.11757158323924,0.208089083693551,-0.5254261872786,0.29028302080012,0.572091414907226
EPHA2,Ephrin type-A receptor 2,Mental health,X29086.Experienced a violent or sexual assault,35040,0.172011495832781,0.193554150005178,-0.207354638177368,0.551377629842929,0.374201116551847
EPHA2,Ephrin type-A receptor 2,Mental health,X29087.Experienced a life-threatening injury or illness,35033,0.316689366542223,0.0919547690391258,0.136458019225537,0.49692071385891,0.000577271867340271
EPHA2,Ephrin type-A receptor 2,Mental health,X29088.Experienced a marital separation or divorce,35039,-0.141764197390217,0.095497518853382,-0.328939334342846,0.0454109395624115,0.13773544548856
EPHA2,Ephrin type-A receptor 2,Mental health,X29089.Experienced the death of a spouse or partner,35046,0.16658763783213,0.101683639439237,-0.0327122954687749,0.365887571133035,0.101414267564988
EPHA2,Ephrin type-A receptor 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35037,-0.023495700334799,0.120348837347384,-0.259379421535672,0.212388020866074,0.845219704279849
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29091.Frequency of drinking alcohol,35037,-0.694606096951893,0.0761465261581739,-0.843853288221914,-0.545358905681872,9.96480094087619e-20
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34310,-0.676392718161811,0.0968451397914668,-0.866209192153086,-0.486576244170536,3.22947855315932e-12
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34334,-0.75654635025924,0.100962886103686,-0.954433607022464,-0.558659093496016,7.86302753465703e-14
EPHA2,Ephrin type-A receptor 2,Mental health,X29104.Ever used cannabis,35038,-0.202054891741265,0.143065030905207,-0.48246235231547,0.0783525688329406,0.157906386824632
EPHA2,Ephrin type-A receptor 2,Mental health,X29108.Ever thought that life not worth living,35007,0.15242337459839,0.102753325455189,-0.048973143293781,0.353819892490561,0.138024737911349
EPHA2,Ephrin type-A receptor 2,Mental health,X29109.Ever contemplated self-harm,35029,0.37296825386668,0.150883734490745,0.0772361342648203,0.66870037346854,0.0134683470414353
EPHA2,Ephrin type-A receptor 2,Mental health,X29111.Ever self-harmed,35038,0.347866842978401,0.266764285737716,-0.174991157067522,0.870724843024324,0.192277008245451
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35026,-0.0435357670116735,0.154318929415693,-0.346000868666431,0.258929334643084,0.7778649354486
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36722,-0.0637581117855772,0.0564321182484934,-0.174365063552624,0.0468488399814699,0.258588256240671
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36722,-0.0362206584814059,0.0410481201876395,-0.116674974049179,0.0442336570863675,0.377591380781188
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36722,-0.0354945891105179,0.0492508772020172,-0.132026308426472,0.0610371302054358,0.471122964074009
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36722,-0.120970486957601,0.0708445683615848,-0.259825840946307,0.0178848670311051,0.0877615137352355
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35019,-0.0198498819353651,0.0878626188258406,-0.192060614834013,0.152360850963283,0.821271931873066
EPHA2,Ephrin type-A receptor 2,Health and medical history,X29153.Pain or discomfort today,35029,0.184655956893546,0.0797520779138708,0.0283418841823588,0.340970029604732,0.0206269560613561
EPHA2,Ephrin type-A receptor 2,Mental health,X29154.Anxiety or depression today,35029,0.0469958940192379,0.10240559637198,-0.153719074869842,0.247710862908318,0.646309295328729
EPHA2,Ephrin type-A receptor 2,Mental health,X29166.Frequency of confiding in someone close,34852,-0.0749435606224658,0.0787113766007094,-0.229217858759856,0.0793307375149246,0.341071127363289
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35013,0.00175677633810667,0.00888536533890864,-0.0156585397261543,0.0191720924023676,0.843274401686988
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35013,-0.00578302375864674,0.0091012981893561,-0.0236215682097847,0.0120555206924912,0.525188334547616
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35013,-0.0374982304590953,0.011413446719301,-0.0598685860289252,-0.0151278748892654,0.00102424836571888
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35013,0.0250200862408122,0.0105782545092409,0.00428670740270002,0.0457534650789244,0.0180511170517815
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35013,-0.0195467616625121,0.0181171502130496,-0.0550563760800893,0.0159628527550652,0.280672886545498
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35013,0.00860632466823792,0.00863165630434156,-0.00831172168827153,0.0255243710247474,0.318774291350208
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35009,-0.0106778562972531,0.00928326473103824,-0.028873055170088,0.00751734257558189,0.250097929399873
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35009,-0.00308056405247184,0.0142284509107582,-0.0309683278375579,0.0248071997326142,0.828599899386117
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35009,-0.0513830532119259,0.0207063197390593,-0.0919674399004821,-0.0107986665233697,0.0131105459155141
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35009,0.0331571602544121,0.0166165372594348,0.000588747225919985,0.0657255732829042,0.0460424243731451
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35009,-0.00164478468937823,0.0280867517368721,-0.0566948180936476,0.0534052487148911,0.95330388853342
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35009,0.0293670084954216,0.0126288192502474,0.00461452276493661,0.0541194942259065,0.0200850141550617
EPHA2,Ephrin type-A receptor 2,Mental health,X29171.Frequency of feeling 'in tune' with people,34909,-0.167295962178562,0.10017682654501,-0.363642542206781,0.0290506178496568,0.0949728288397878
EPHA2,Ephrin type-A receptor 2,Mental health,X29172.Freuency of feeling that lacks companionship,34990,0.218102182089827,0.090091304999388,0.0415232242910263,0.394681139888627,0.0155125951566314
EPHA2,Ephrin type-A receptor 2,Mental health,X29173.Frequency of feeling left out,34950,0.0917868106367516,0.0964204059096486,-0.0971971849461597,0.280770806219663,0.341165446308108
EPHA2,Ephrin type-A receptor 2,Mental health,X29174.Frequency of feeling isolated from others,34981,0.129205680987408,0.0998076219420085,-0.066417258018929,0.324828619993744,0.195528124871354
EPHA2,Ephrin type-A receptor 2,Mental health,X29175.Tendency to bounce back quickly after hard times,35024,0.0355323917156403,0.0803722214985639,-0.121997162421545,0.193061945852825,0.658434758732189
EPHA2,Ephrin type-A receptor 2,Mental health,X29176.Ability to make it through stressful events,35024,0.0756368718415775,0.0772050378857946,-0.07568500241458,0.226958746097735,0.327280678503876
EPHA2,Ephrin type-A receptor 2,Mental health,X29177.Quick recovery from stressful events,35024,0.0275273665026427,0.0792611822729588,-0.127824550752357,0.182879283757642,0.728378892589222
EPHA2,Ephrin type-A receptor 2,Mental health,X29178.Hard to snap back when something bad happens,35024,0.0520397280913226,0.077276016121575,-0.0994212635069644,0.20350071968961,0.500702612112804
EPHA2,Ephrin type-A receptor 2,Mental health,X29179.Comes through difficult times with little trouble,35024,-0.0737486606735663,0.0786448696106324,-0.227892605110406,0.0803952837632731,0.348415465163145
EPHA2,Ephrin type-A receptor 2,Mental health,X29180.Tendency to take a long time to get over setbacks,35024,0.11453437769462,0.0780636468685134,-0.0384703701676666,0.267539125556906,0.142377732976856
EPHA2,Ephrin type-A receptor 2,Mental health,X29181.General happiness,34997,0.0531765392741826,0.0803011409152837,-0.104213696919773,0.210566775468139,0.507860401851811
EPHA2,Ephrin type-A receptor 2,Mental health,X29182.Belief that own life is meaningful,34906,0.00273867155449327,0.0802378097773867,-0.154527435609185,0.160004778718171,0.972773137620891
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,35340,0.0516145363512579,0.0638763780410177,-0.0735831646091368,0.176812237311653,0.419100020309085
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2946.Father's age,30123,0.00569218795006425,0.0209516544090706,-0.0353730546917142,0.0467574305918426,0.785926883605133
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2966.Age high blood pressure diagnosed,36538,-0.0306982824305475,0.00506367151587258,-0.0406230786016577,-0.0207734862594372,1.40692830678322e-09
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,50806,0.0197722370393185,0.0026490687253397,0.0145800623376527,0.0249644117409844,8.72113333529835e-14
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,50807,-0.0485068620322701,0.00277024281037708,-0.0539365379406092,-0.0430771861239311,3.55624287476481e-68
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30020.Haemoglobin concentration,50807,-0.0769979514743,0.00295257797387689,-0.0827850043030987,-0.0712108986455013,1.2345767535983e-147
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30030.Haematocrit percentage,50807,-0.0659096105602409,0.00288295628001262,-0.0715602048690657,-0.0602590162514162,2.5295050085716e-114
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30040.Mean corpuscular volume,50807,-0.0136538700231496,0.00255828685475559,-0.0186681122584705,-0.00863962778782865,9.53890300702926e-08
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,50807,-0.0225266943002829,0.00256286375852835,-0.0275499072669985,-0.0175034813335674,1.60999079648479e-18
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,50807,-0.0217704546446858,0.00249938772095848,-0.0266692545777644,-0.0168716547116072,3.24408837965596e-18
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,50807,0.0524657873430945,0.0025672124062025,0.0474340510269376,0.0574975236592514,5.81961537007318e-92
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30080.Platelet count,50807,-0.0114642830276342,0.00253472670886225,-0.0164323473770042,-0.00649621867826421,6.13260506157436e-06
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30090.Platelet crit,50807,-0.00725945536438656,0.00257908041435578,-0.0123144529765239,-0.00220445775224923,0.00488599892932854
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,50807,0.00946685827048825,0.00242099775343145,0.00472170267376261,0.0142120138672139,9.24582096718455e-05
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30110.Platelet distribution width,50807,0.00746351835460149,0.00250920565201039,0.00254547527666112,0.0123815614325418,0.00293834078299909
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30120.Lymphocyte count,50768,-0.0171348367656382,0.00248693437818135,-0.0220092281468736,-0.0122604453844028,5.73516160735767e-12
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30130.Monocyte count,50768,0.0159336519113966,0.00255116810016924,0.0109333624350649,0.0209339413877283,4.29978971026102e-10
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30140.Neutrophill count,50768,0.0223579913246253,0.002624508766162,0.0172139541429478,0.0275020285063028,1.71439254474688e-17
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30150.Eosinophill count,50768,0.0344521478888315,0.00249495375722541,0.0295620385246697,0.0393422572529933,3.44734166379721e-43
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30160.Basophill count,50768,0.0725799927289895,0.0389175230698819,-0.00369835248797901,0.148858337945958,0.0621992492333877
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30170.Nucleated red blood cell count,50768,0.360099972917267,0.174939440126513,0.0172186702693017,0.702981275565233,0.0395611957090467
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30180.Lymphocyte percentage,50769,-0.0309935727857559,0.00247526598788387,-0.0358450941220083,-0.0261420514495036,7.60667987742991e-36
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30190.Monocyte percentage,50769,0.00340850859091112,0.00252246000767584,-0.00153551302413352,0.00835253020595576,0.176625151085357
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30200.Neutrophill percentage,50769,0.0183797254116119,0.00246315333795523,0.0135519448692197,0.0232075059540041,8.8532044044024e-14
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30210.Eosinophill percentage,50769,0.0278737237769679,0.00247763230285545,0.0230175644633712,0.0327298830905646,2.7897943776584e-29
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30220.Basophill percentage,50769,-0.00195766117051084,0.00247779655805292,-0.00681414242429456,0.00289882008327287,0.429488868704892
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,50768,0.359218935532865,0.175011948698431,0.0161955160839412,0.70224235498179,0.0401292988855228
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30240.Reticulocyte percentage,50429,0.00822656717353539,0.00268831101475501,0.00295747758461557,0.0134956567624552,0.00221520725758086
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30250.Reticulocyte count,50429,-0.00325281861372463,0.00273701426912252,-0.00861736658120476,0.0021117293537555,0.234667443514409
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30260.Mean reticulocyte volume,50429,0.020924390436103,0.00251201170649661,0.0160008474913696,0.0258479333808364,8.58772678534358e-17
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30270.Mean sphered cell volume,50429,-0.00227683293593334,0.00254839844125734,-0.00727169388079772,0.00271802800893104,0.371633430596363
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30280.Immature reticulocyte fraction,50429,0.0130641477563691,0.0026558816359565,0.00785861974989435,0.0182696757628438,8.76603504761538e-07
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50429,0.0123516375567358,0.00273865587791999,0.00698387203601265,0.017719403077459,6.51410327507232e-06
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30300.High light scatter reticulocyte count,50429,0.0031328912734847,0.00277586636601223,-0.00230780680389926,0.00857358935086866,0.259071988299947
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30500.Microalbumin in urine,36877,0.0786265893827975,0.00458593338372978,0.0696381599506871,0.0876150188149078,1.08000946538326e-64
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,50781,0.00945074790477334,0.00275991981549982,0.0040413050663937,0.014860190743153,0.000617568240292707
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30520.Potassium in urine,50745,-0.0196371792923274,0.00258996727492198,-0.0247135151511745,-0.0145608434334803,3.53959826039546e-14
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30530.Sodium in urine,50731,-0.00918378642263911,0.00272018278679126,-0.01451534468475,-0.00385222816052823,0.000736336630362477
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30600.Albumin,48630,-0.0735182084139189,0.00263311789271259,-0.0786791194836356,-0.0683572973442022,3.10099832574403e-168
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30610.Alkaline phosphatase,50405,0.078529315650371,0.0025932847565108,0.0734464775276099,0.0836121537731322,3.10647800012718e-197
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30620.Alanine aminotransferase,50410,-0.0107453787862434,0.00281874433807726,-0.0162701176888748,-0.00522063988361193,0.000138171907904173
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30630.Apolipoprotein A,48488,-0.049515279634546,0.00292478249464302,-0.0552478533240463,-0.0437827059450457,7.87319599711101e-64
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30640.Apolipoprotein B,50307,-0.0278300266521696,0.00245129673274763,-0.0326345682483549,-0.0230254850559842,8.72506067715692e-30
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30650.Aspartate aminotransferase,50348,0.0161036984298306,0.00268898004400757,0.0108332975435758,0.0213740993160855,2.14841253062536e-09
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30660.Direct bilirubin,47329,0.000371691697891838,0.00281798977870304,-0.00515156826836612,0.0058949516641498,0.895065175760104
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30670.Urea,50392,0.0958275845444766,0.00252596951120426,0.0908766843025162,0.100778484786437,9.28883727389363e-305
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30680.Calcium,48630,-0.0309547145155483,0.00259590763419991,-0.0360426934785801,-0.0258667355525165,1.14782723019733e-32
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30690.Cholesterol,50412,-0.0356153897337411,0.00246944669996524,-0.040455505265673,-0.0307752742018093,6.23677925084167e-47
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30700.Creatinine,50403,0.161542536501006,0.00268272844400225,0.156284388750762,0.166800684251251,0
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30710.C-reactive protein,50350,0.0372705978262481,0.00280440410251469,0.0317739657853193,0.0427672298671769,3.83204519299955e-40
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30720.Cystatin C,50418,0.234092068901818,0.00237080653794157,0.229445288087453,0.238738849716184,0
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30730.Gamma glutamyltransferase,50406,-0.00245138759616763,0.00283746498577869,-0.00801281896829388,0.00311004377595861,0.387632925218082
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30740.Glucose,48614,0.000138493374688173,0.0026746744013251,-0.00510386845190902,0.00538085520128537,0.95870490151529
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50381,0.0201196742384566,0.00270117410866628,0.0148253729854707,0.0254139754914425,9.8026009857701e-14
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30760.HDL cholesterol,48620,-0.0567113987352166,0.0029974014938218,-0.0625863056631073,-0.0508364918073259,4.00263771794517e-79
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30770.IGF-1,50286,-0.00919035776252343,0.00259362550193295,-0.014273863746312,-0.00410685177873484,0.000395795697554054
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30780.LDL direct,50362,-0.0283820034027401,0.00242737945746996,-0.0331396671393813,-0.023624339666099,1.74119686203832e-31
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30790.Lipoprotein A,46103,-0.00154596832555813,0.00276214824485014,-0.00695977888546441,0.00386784223434815,0.575692989657809
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30810.Phosphate,48591,0.0173141356129073,0.00279455625515495,0.0118368053528036,0.022791465873011,5.92084629193061e-10
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30830.SHBG,48466,0.0430504856876574,0.00320930730413938,0.0367602433715442,0.0493407280037705,7.60850179757614e-41
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30840.Total bilirubin,50327,-0.0216491802372321,0.00273210649465318,-0.0270041089667523,-0.0162942515077118,2.41325725747192e-15
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30850.Testosterone,47922,-0.00771790750059247,0.00431881500015927,-0.0161827849009046,0.000746969899719701,0.0739467293080448
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30860.Total protein,48613,-0.0284287349172856,0.0026028995223177,-0.0335304179810283,-0.0233270518535429,1.08984410945766e-27
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30870.Triglycerides,50400,0.0193097678594124,0.00283661459625761,0.0137500032507475,0.0248695324680773,1.02083386434474e-11
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30880.Urate,50381,0.0695974135898095,0.00301651170238781,0.0636850506531294,0.0755097765264896,2.39311635206989e-116
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30890.Vitamin D,49339,-0.0107716141094009,0.00288068981836079,-0.0164177661533881,-0.00512546206541378,0.00018508233664939
EPHA2,Ephrin type-A receptor 2,Physical measures,X3137.Number of measurements made,48998,-0.023339337862235,0.0464151661416014,-0.114313063499774,0.0676343877753036,0.615083333983772
EPHA2,Ephrin type-A receptor 2,Physical measures,X3143.Ankle spacing width,41803,0.0189475790495647,0.0043138843773655,0.0104923656699284,0.0274027924292011,1.13108065745747e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",41802,-0.0178221562872706,0.00335975907909705,-0.0244072840823008,-0.0112370284922404,1.14834733988582e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,X3146.Speed of sound through heel,41803,-0.0249952044263322,0.0032140250878218,-0.0312946935984629,-0.0186957152542015,8.0075043005232e-15
EPHA2,Ephrin type-A receptor 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",41803,-0.0231597099565598,0.00325539606873123,-0.029540286251273,-0.0167791336618466,1.18602693247446e-12
EPHA2,Ephrin type-A receptor 2,Physical measures,X3148.Heel bone mineral density (BMD),41791,-0.0229987697030812,0.00325883869209591,-0.0293860935395892,-0.0166114458665732,1.78595941598828e-12
EPHA2,Ephrin type-A receptor 2,Health and medical history,X3526.Mother's age at death,47672,-0.00718372369082557,0.00258060018487334,-0.0122417000531773,-0.00212574732847381,0.00537904526828195
EPHA2,Ephrin type-A receptor 2,Health and medical history,X3581.Age at menopause (last menstrual period),38175,-0.011040465009683,0.00347925118520428,-0.0178597973326834,-0.00422113268668259,0.00151261103394041
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32690,-0.00352539187793529,0.00536064027397353,-0.0140322468149234,0.00698146305905283,0.510810335009135
EPHA2,Ephrin type-A receptor 2,Physical measures,X4100.Ankle spacing width (left),36493,0.0153428580116172,0.00579210628579663,0.00399032969145584,0.0266953863317786,0.00809219949083393
EPHA2,Ephrin type-A receptor 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36490,-0.00948989257796174,0.00450817023582679,-0.0183259062401822,-0.000653878915741231,0.0353216593370298
EPHA2,Ephrin type-A receptor 2,Physical measures,X4103.Speed of sound through heel (left),36493,-0.0214812033692086,0.00430041422088643,-0.029910015242146,-0.0130523914962712,6.01560311496692e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36493,-0.0175728857595391,0.00436048292444962,-0.0261194322914604,-0.00902633922761788,5.63359391441543e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),36489,-0.0176228655237873,0.00435854059467437,-0.0261656050893491,-0.00908012595822555,5.32478143452993e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36493,-0.0175684111831435,0.00436046247198345,-0.026114917628231,-0.00902190473805593,5.65772975749854e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X4119.Ankle spacing width (right),36488,0.0130461107006296,0.00571166509381864,0.00185124711674504,0.0242409742845141,0.0223932652520147
EPHA2,Ephrin type-A receptor 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36487,-0.0174533020260958,0.00450311670554441,-0.0262794107689629,-0.0086271932832288,0.000107195019445974
EPHA2,Ephrin type-A receptor 2,Physical measures,X4122.Speed of sound through heel (right),36488,-0.0252824128460133,0.00429195008943751,-0.0336946350213109,-0.0168701906707158,4.01755081394857e-09
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36488,-0.0230251229044677,0.00435203995799662,-0.031555121222141,-0.0144951245867943,1.25427445808637e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),36483,-0.023956006322006,0.00434978218094089,-0.0324815793966501,-0.0154304332473618,3.76576893326135e-08
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36488,-0.0230202847501153,0.0043520330393825,-0.031550269507305,-0.0144902999929256,1.26183432280808e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,X4194.Pulse rate,36829,0.00856902051940592,0.0041339545861329,0.000466469530585437,0.0166715715082264,0.038220776414222
EPHA2,Ephrin type-A receptor 2,Physical measures,X4195.Pulse wave reflection index,36829,-0.00982590445892163,0.00445833621360075,-0.0185642434375791,-0.00108756548026416,0.0275583159825156
EPHA2,Ephrin type-A receptor 2,Physical measures,X4196.Pulse wave peak to peak time,36823,0.00180827875059981,0.00409864477910481,-0.00622506501644562,0.00984162251764524,0.65908836794417
EPHA2,Ephrin type-A receptor 2,Physical measures,X4198.Position of the pulse wave peak,36829,-0.000802663400193414,0.00436669935716718,-0.0093613941402411,0.00775606733985427,0.854163728773617
EPHA2,Ephrin type-A receptor 2,Physical measures,X4199.Position of pulse wave notch,36829,0.00974058875596303,0.00417053729072167,0.00156633566614856,0.0179148418457775,0.0195393354047368
EPHA2,Ephrin type-A receptor 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,36829,0.00379534775171098,0.00431063557994396,-0.00465349798497918,0.0122441934884011,0.378637181059423
EPHA2,Ephrin type-A receptor 2,Physical measures,X4269.Number of triplets attempted (left),36643,-0.0563992899920567,0.167056704050031,-0.383830429930118,0.271031849946004,0.735669901821512
EPHA2,Ephrin type-A receptor 2,Physical measures,X4270.Volume level set by participant (left),36551,-0.0100400201253556,0.0591278930189642,-0.125930690442525,0.105850650191814,0.865170715693885
EPHA2,Ephrin type-A receptor 2,Physical measures,X4276.Number of triplets attempted (right),36636,-0.184014131839944,0.162274744066257,-0.502072630209807,0.134044366529918,0.256845169056572
EPHA2,Ephrin type-A receptor 2,Physical measures,X4277.Volume level set by participant (right),36548,0.0118186410326074,0.0591921616927758,-0.104197995885233,0.127835277950448,0.841747608165408
EPHA2,Ephrin type-A receptor 2,Cognitive function,X4288.Time to answer,36829,0.00197814077315704,0.00490463899315318,-0.0076349516534232,0.0115912331997373,0.686723858336389
EPHA2,Ephrin type-A receptor 2,Cognitive function,X4290.Duration screen displayed,36829,0.0189957023241677,0.00461224723904582,0.00995569773563787,0.0280357069126975,3.85311034451923e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X46.Hand grip strength (left),51374,-0.0543887125826774,0.0035356729874484,-0.0613186316380763,-0.0474587935272785,4.01401147823504e-53
EPHA2,Ephrin type-A receptor 2,Physical measures,X47.Hand grip strength (right),51399,-0.0511012710147814,0.00351002591078998,-0.0579809217999297,-0.044221620229633,8.54634221121324e-48
EPHA2,Ephrin type-A receptor 2,Physical measures,X48.Waist circumference,51462,0.0282794940482492,0.00538164997096735,0.0177314601051532,0.0388275279913452,1.49549670954983e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,X4803.Tinnitus,36740,0.100311604696487,0.0651880128239991,-0.0274569004385514,0.228080109831525,0.123893986734809
EPHA2,Ephrin type-A receptor 2,Working and living environment,X4825.Noisy workplace,36812,0.0979531195699188,0.0744777695368284,-0.0480233087222648,0.243929547862102,0.188482483997371
EPHA2,Ephrin type-A receptor 2,Working and living environment,X4836.Loud music exposure frequency,36770,0.0163797479590954,0.123841712919442,-0.226350009363012,0.259109505281203,0.894779328745113
EPHA2,Ephrin type-A receptor 2,Physical measures,X49.Hip circumference,51457,-0.00207108276760782,0.00440412644058849,-0.0107031705911613,0.00656100505594561,0.638174159304028
EPHA2,Ephrin type-A receptor 2,Physical measures,X50.Standing height,51437,0.0172079978412385,0.00349021296103601,0.0103671804376079,0.024048815244869,8.2670225173746e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,X5057.Number of older siblings,35645,0.00677122537997231,0.0633937945260053,-0.117480611890998,0.131023062650943,0.914941356584445
EPHA2,Ephrin type-A receptor 2,Physical measures,X51.Seated height,51359,0.00340205341733452,0.00326502391073447,-0.00299739344770504,0.00980150028237409,0.297437456349749
EPHA2,Ephrin type-A receptor 2,Eye measures,X5181.Ever had eye surgery,34318,0.375202520665635,0.123497484304186,0.13314745142943,0.61725758990184,0.00239244184060648
EPHA2,Ephrin type-A receptor 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),34304,0.00827223699058368,0.00498404070678141,-0.00149648279470789,0.0180409567758752,0.0970271087829851
EPHA2,Ephrin type-A receptor 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),34303,0.0110199948889572,0.00511184387881647,0.00100078088647695,0.0210392088914375,0.0311476397188507
EPHA2,Ephrin type-A receptor 2,Eye measures,X5190.Duration at which refractometer first shown (right),34238,0.00776171973532071,0.00523346074876019,-0.00249586333224926,0.0180193028028907,0.138111635318418
EPHA2,Ephrin type-A receptor 2,Eye measures,X5193.Duration at which refractometer first shown (left),34236,0.0106147905291868,0.00527196602277259,0.000281737124552487,0.0209478439338211,0.044121334148432
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5199.logMAR, initial (right)",34287,0.0532770540247906,0.0769813871228014,-0.0976064647359002,0.204160572785481,0.488920477133189
EPHA2,Ephrin type-A receptor 2,Eye measures,X5200.Final number of letters displayed (right),34287,-0.419978243632323,0.390520297337813,-1.18539802641444,0.34544153914979,0.282232073281647
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5201.logMAR, final (right)",34230,0.00903645965926236,0.00552132947531688,-0.00178534611235872,0.0198582654308834,0.101767023587684
EPHA2,Ephrin type-A receptor 2,Eye measures,X5202.Number of rounds to result (right),34287,-0.0363879669092652,0.0704031656478527,-0.174378171579057,0.101602237760526,0.605282464773729
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5206.logMAR, initial (left)",34284,-0.0092343973209866,0.0768053836718565,-0.159772949317825,0.141304154675852,0.904304812393971
EPHA2,Ephrin type-A receptor 2,Eye measures,X5207.Final number of letters displayed (left),34284,-0.102559717391867,0.411041642468032,-0.908201336629209,0.703081901845475,0.802975029288509
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5208.logMAR, final (left)",34225,0.00679039307032667,0.00550031430558926,-0.00399022296862827,0.0175710091092816,0.217057036667744
EPHA2,Ephrin type-A receptor 2,Eye measures,X5209.Number of rounds to result (left),34282,-0.0550285222449305,0.0704036966343655,-0.193019767648287,0.0829627231584258,0.434477842729268
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",34044,-0.0127488020401488,0.00509703452608072,-0.022738989711267,-0.00275861436903057,0.0124093577895733
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",34044,-0.0159801034983858,0.00515738193824834,-0.0260885720973525,-0.00587163489941902,0.00195621780544919
EPHA2,Ephrin type-A receptor 2,Eye measures,X5256.Corneal hysteresis (right),34044,-0.000455676768110909,0.00514000515569855,-0.0105300868732801,0.00961873333705825,0.929361363079535
EPHA2,Ephrin type-A receptor 2,Eye measures,X5257.Corneal resistance factor (right),34044,-0.00883989106047468,0.00518855751920484,-0.0190094637981162,0.00132968167716681,0.0884959627495841
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",34038,-0.0151683891222592,0.00509932020916974,-0.0251630567322318,-0.00517372151228648,0.00294827607699815
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",34038,-0.0182829149848645,0.00514878083041651,-0.0283745254124809,-0.00819130455724815,0.000387534157912561
EPHA2,Ephrin type-A receptor 2,Eye measures,X5264.Corneal hysteresis (left),34038,0.000913069532408764,0.00522423216524278,-0.00932642551146708,0.0111525645762846,0.861263082241253
EPHA2,Ephrin type-A receptor 2,Eye measures,X5265.Corneal resistance factor (left),34038,-0.009239905039406,0.00524768430464625,-0.0195253662765126,0.00104555619770066,0.0783423694370305
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34415,0.649677855554964,0.36349727014409,-0.0627767939274522,1.36213250503738,0.0739473757888401
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51412,0.0434588719102805,0.013101129478042,0.0177806581333182,0.0691370856872428,0.000910752389696315
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51412,0.0536161693028164,0.0139445648315186,0.0262848222330401,0.0809475163725928,0.000120912596618509
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51412,0.0331799465996166,0.0375631835477933,-0.0404438931540582,0.106803786353291,0.377078202283239
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51412,-0.0138081359570241,0.00566306030531619,-0.0249077341554438,-0.00270853775860435,0.0147650518280522
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51412,-0.00154167014666361,0.00533380136961682,-0.0119959208311126,0.00891258053778536,0.772555157526856
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37973,-0.0434204876385357,0.00801351152596541,-0.0591269702294279,-0.0277140050476435,6.17240067979739e-08
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37973,-0.00755681114046723,0.0172293779135732,-0.0413263918510707,0.0262127695701363,0.660961938002427
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37973,-0.0224411130282672,0.0212507861308142,-0.0640926538446631,0.0192104277881287,0.290991192435937
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37973,0.0197832855916553,0.0113935046556733,-0.00254798353346447,0.042114554716775,0.0825343526806184
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51474,0.00865611221523199,0.0111253661782784,-0.0131496054941937,0.0304618299246577,0.436546683558357
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51474,0.00865611221523199,0.0111253661782784,-0.0131496054941937,0.0304618299246577,0.436546683558357
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51474,-0.00366763560696641,0.00886242108048426,-0.0210379809247155,0.0137027097107827,0.678994339922939
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51474,-0.0265322967776283,0.0153769395716473,-0.056671098338057,0.00360650478280032,0.0844584418178258
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51474,0.0590878112030605,0.0368633656952188,-0.0131643855595685,0.131340007965689,0.108973770456144
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51474,0.0481901666062917,0.0252708581618811,-0.00134071539099513,0.0977210486035786,0.0565404048103311
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51474,-0.0512398495649709,0.041144454946114,-0.131882981259354,0.0294032821294125,0.213010839795193
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51412,0.00559973702973961,0.0082031148250192,-0.010478368027298,0.0216778420867772,0.494844340920618
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51412,0.0378770810501782,0.0137226415456347,0.0109807036207342,0.0647734584796222,0.00578153162304636
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51412,-0.0114222818653541,0.00821713062977884,-0.0275278578997206,0.00468329416901239,0.164525424437402
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51412,0.0133846648411643,0.0115770312955089,-0.00930631649803319,0.0360756461803617,0.247636474070848
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51412,0.00575867242468505,0.0140825445284777,-0.0218431148511312,0.0333604597005013,0.682600315870799
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51412,0.0525465310408201,0.00547856106047606,0.041808551362287,0.0632845107193532,9.58423223203606e-22
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,38547,0.0465679549871874,0.0139521891826667,0.0192216641891606,0.0739142457852142,0.000848103756541921
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,38547,0.00688009706461264,0.0119125631529405,-0.0164685267151508,0.030228720844376,0.56358208930554
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,38547,0.107853138915387,0.0170942296049961,0.0743484488895945,0.141357828941179,2.92950833141581e-10
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,38547,0.021170875781815,0.0134379486270556,-0.00516750352721403,0.0475092550908441,0.115185409100441
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51392,-0.0102768850412554,0.0188937529818966,-0.0473086408857728,0.0267548708032619,0.58649488871302
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51392,0.0031207679780687,0.028664672721232,-0.053061990555546,0.0593035265116835,0.91330533895883
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51392,0.0717099373181614,0.0453177913265008,-0.0171129336817802,0.160532808318103,0.113577241768345
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51392,-0.012043632288715,0.0471984711869601,-0.104552635815157,0.0804653712377268,0.798594191049787
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51392,0.00800011501274567,0.0155983647423367,-0.0225726798822342,0.0385729099077256,0.608039215305583
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51392,0.057183749590566,0.0214586503189247,0.0151247949654736,0.0992427042156584,0.00770819384137122
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51392,0.00490612611308078,0.0113597572398015,-0.0173589980769302,0.0271712503030917,0.665828081450924
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35781,0.0804610483544422,0.0154704380746047,0.050138989728217,0.110783106980667,2.04247226118644e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35781,0.0632920507228825,0.0163122759943712,0.0313199897739151,0.09526411167185,0.000105464067510103
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35781,0.115674869077279,0.0227573715634284,0.0710704208129596,0.160279317341599,3.81837874455268e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35781,0.0115200885548799,0.00950958743391743,-0.00711870281559827,0.030158879925358,0.225778573833864
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",40200,0.0275037379884583,0.00772353715770099,0.0123656051593644,0.0426418708175523,0.000370963819063873
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",40200,-0.036524902485135,0.00911854894665355,-0.054397258420576,-0.018652546549694,6.22774097771973e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",40200,0.00820180809476719,0.00755830601826587,-0.00661247170103391,0.0230160878905683,0.277884130300874
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",40200,0.0265224221690777,0.0174659488663227,-0.0077108376089148,0.0607556819470702,0.128911659360596
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",40200,0.0639958026660592,0.00969389326261025,0.0449957718713431,0.0829958334607753,4.25283301488626e-11
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",40200,0.0214848756726587,0.0137864366813377,-0.00553654022276321,0.0485062915680806,0.119165615331392
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51412,-0.0163827476773368,0.0153826035807757,-0.0465326506956572,0.0137671553409835,0.286879417541437
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51412,0.00564087482821139,0.0116393877112306,-0.0171723250858006,0.0284540747422234,0.627938830237001
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51412,0.0693021256198123,0.0295588696959763,0.0113667410156987,0.127237510223926,0.0190590241127345
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51412,-0.0213252774430302,0.0108302846466306,-0.0425526353504261,-9.79195356342853e-05,0.0489607598135683
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51412,-0.0113590786893887,0.012784002211186,-0.0364157230233133,0.0136975656445359,0.374260752347565
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51412,0.0582109720490977,0.0152594208087969,0.0283025072638559,0.0881194368343396,0.000136686215218961
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51412,0.00697021672140565,0.00512710769211392,-0.00307891435513764,0.0170193477979489,0.174007322599767
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34695,0.070030143180059,0.0135651353949318,0.0434424778059926,0.0966178085541253,2.52226888210095e-07
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34695,0.0816194206695772,0.0166035856230994,0.0490763928483025,0.114162448490852,9.10007152956122e-07
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34695,-0.0671252407514016,0.0115833569440985,-0.0898286203618348,-0.0444218611409685,7.21264559438995e-09
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34695,0.0131766390603319,0.0109193875564431,-0.00822536055029647,0.0345786386709603,0.2275920254971
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51496,0.0161811356674164,0.00685637260981217,0.00274264535218459,0.0296196259826483,0.0182828053935299
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51496,0.030287667096224,0.0190215196088808,-0.00699451133718241,0.0675698455296303,0.111335010571964
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51496,0.0101489499407689,0.00569411025283141,-0.00101150615478064,0.0213094060363185,0.0747042703663327
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51496,0.0245243216289169,0.00548679802216538,0.0137701975054728,0.0352784457523611,7.87163308052555e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51496,0.044442552306554,0.00936393960453799,0.0260892306816595,0.0627958739314484,2.08622436427657e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51496,0.0312948826741022,0.00700930919639601,0.017556636649166,0.0450331286990384,8.05515657142904e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51496,0.0134010279480586,0.00573540590265165,0.00215963237886135,0.0246424235172558,0.0194717170594395
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51496,0.13042269859692,0.0174592269336723,0.0962026138069222,0.164642783386918,8.30595388689925e-14
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45029,-0.030976550081296,0.00582447559444477,-0.0423925222464077,-0.0195605779161842,1.0614021847946e-07
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45029,-0.0237042727879239,0.00606740358030669,-0.035596383805325,-0.0118121617705228,9.39061855503339e-05
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45029,0.0311961551871985,0.0064151079226357,0.0186225436588325,0.0437697667155644,1.16777180426468e-06
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45029,-0.0108264377870367,0.00876811669274615,-0.0280119465048191,0.0063590709307458,0.216941640622607
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45029,0.00385524095635231,0.00585643594531077,-0.0076233734964568,0.0153338554091614,0.510360523956624
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51282,-0.00642987932107836,0.00599126515443197,-0.018172759023765,0.0053130003816083,0.28318910528277
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51282,-0.0343773852464739,0.00486083453338649,-0.0439046209319114,-0.0248501495610364,1.56907862013296e-12
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51282,-0.00740885586770641,0.00503320026466119,-0.0172739283864423,0.00245621665102952,0.141035925523767
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51282,-0.0365768559429938,0.0108981510487609,-0.0579372319985652,-0.0152164798874224,0.000791419534292057
EPHA2,Ephrin type-A receptor 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51300,-0.060248284168054,0.00538913658266323,-0.070810991870074,-0.0496855764660341,6.13823542645774e-29
EPHA2,Ephrin type-A receptor 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51300,-0.0349270538785008,0.0106402703648282,-0.0557819837935641,-0.0140721239634376,0.00103037997457076
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51412,-0.0371687260200242,0.0049497119663549,-0.0468701614740798,-0.0274672905659686,6.1697416010432e-14
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51412,-0.031339982227241,0.00567648892598114,-0.042465900522164,-0.020214063932318,3.4081588525352e-08
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51412,0.00415201988380927,0.00858873899712294,-0.0126819085505517,0.0209859483181702,0.628798042779191
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51412,-0.0186038074625892,0.0118442248424308,-0.0418184881537535,0.00461087322857516,0.116264950780937
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51412,0.0630726075396127,0.0150260414393366,0.033621566318513,0.0925236487607123,2.70863267407741e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51412,-0.0220007498695491,0.0143331499851485,-0.0500937238404401,0.00609222410134184,0.124808956035773
EPHA2,Ephrin type-A receptor 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",41803,-0.0231581736232178,0.00325538608820116,-0.0295387303560921,-0.0167776168903436,1.18988794936227e-12
EPHA2,Ephrin type-A receptor 2,Physical activities,X864.Number of days or week walked 10+ minutes,50919,-0.227215853520903,0.0355445936351783,-0.296883257045852,-0.157548449995953,1.66603825008418e-10
EPHA2,Ephrin type-A receptor 2,Physical activities,X874.Duration of walks,47944,-0.00408653530552745,0.00265875551711512,-0.00929769611907308,0.00112462550801819,0.124307597270169
EPHA2,Ephrin type-A receptor 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50019,-0.236775590114482,0.0345692115517519,-0.304531244755916,-0.169019935473049,7.62710417149637e-12
EPHA2,Ephrin type-A receptor 2,Physical activities,X894.Duration of moderate activity,45347,-0.0542026837519007,0.0432669270866704,-0.139005860841775,0.0306004933379732,0.210314496072315
EPHA2,Ephrin type-A receptor 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,33326,-0.0153035874916302,0.00585056114020891,-0.0267706873264397,-0.00383648765682074,0.008935635303329
EPHA2,Ephrin type-A receptor 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,49927,-0.320717793935162,0.0362403946770906,-0.391748967502259,-0.249686620368064,9.46255838682572e-19
EPHA2,Ephrin type-A receptor 2,Physical activities,X914.Duration of vigorous activity,40013,0.0069544776508767,0.00310274256976633,0.000873102214134685,0.0130358530876187,0.0250205694095028
